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ABSTRACT
The ability to express and purify large quantities of recombinant protein allows
for biotechnological applications such as: protein characterization, usage in industrial

processes, the development of commercial goods, and other advanced studies. In the
classical methods of protein expression, cells are grown to the mid-log phase and are

induced via a simple sugar or a chemical agent. Post-induction, the energy used for
cellular growth is redirected for the production of ELPs. Samples are collected and

analyzed for cell count and harvested for fluorescence spectroscopy and protein
purification. Optimization of protein expression of an elastin-like-polypeptide and green
fluorescence protein fusion (ELP-GFP fusion protein) is achieved by targeting the
organisms, expression systems, altering media formulations, antibiotic resistance, and

selective inducers for optimal production of ELP-GFP fusion proteins. We investigate

which organism and expression system, after optimizing the conditions, yields maximum
amount of ELP-GFP fusion protein by quantifying with fluorescence and absorbance at
280 nm.

The bacterial host, BL21 (DE3), gave optimal expression of ELP-GFP when

induced with lactose and galactose. The yields were between 400-600 mg/L of culture,
much higher than when expressed in LB media and induced with IPTG. The Vmax strain,

which has a doubling rate of less than 10 minutes, however, it is not optimized for protein
expression. For a different ELP-GFP fusion protein, the protein yields after purification

v

were between 200-300 mg/L for BL21 (DE3) and between 100-200 mg/L for Vmax

derived cells.
The lac and the ara operons do not behave the same way during protein
expression. The lac system suffers from “leaky” expression whereas the ara system is

more tightly regulated. Fluorescence was used as a reliable means to understand the

behavior of my ELP-GFP proteins. The fluorescence data revealed that the lac operon is
more stable for longer fermentations times whereas, the ara operon is more suitable for

shorter fermentation times.
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CHAPTER I

BACKGROUND

1.1 Gene Regulation in Bacteria

For cells to generate protein, an energy source must be present for metabolism to
occur. In the absence of a carbon-energy source, cells are unable to metabolize or
facilitate cell transport of the energy needed within the system.[1] In the presence of
multiple carbon-energy sources in the complex media, cells will consume one carbon-

energy source before consuming another.[2] Glucose, a simple sugar, is the preferred
carbon-energy source for E. coli; metabolic pathways have evolved to allow for effective

oxidation of glucose.[3] It is the preferred energy source of E. coli because of catabolite

repression, which allows cells to adjust to glucose and ultimately consume it while
preventing the uptake of other carbon-energy sources from being utilized.[4, 5] In E. coli,

the carbon-energy sources such as arabinose, galactose, and lactose are only used once
the glucose is depleted if and only if the particular strain can digest and transport that

specific carbon-energy source.[6, 7]
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In the absence of an inducing agent (a chemical or simple sugar), a regulatory

gene acts as a repressor that restrains its own gene expression.[8] However, an inducible
system, is turned on when the inducer or another chemical agent, which will allow for

gene expression to occur, is present. Inducing a gene can be either positive, where

something is added to express, or negative which eliminates an inhibitor or downplays it
to stimulate gene expression. The essential genes responsible for RNA transcription,

DNA replication, and protein translation are always expressed.[9] In currently known
genomic structures of E. coli, DNA is reported to code for up to 5,500 genes and over
4,000 proteins. [6] Bacterial hosts use regulatory proteins to control expression of genes
by adapting to their environment.[10-13] Gene expression in the organism depends on the

food and energy sources present in the complex media. Additionally, genes are further
managed by arranging into an operon, a cluster of genes, usually oriented in the same

direction and adjacent to one another on the chromosome.[3, 9] The control genes and
those clustered into an operon are controlled at the same time.

Gene transcription begins when the RNA polymerase (a DNA-binding protein)
binds to the promoter (a DNA-binding site).[11, 13, 14] A single strand of mRNA for all
the genes coded for a specific operon is the product of transcription.[15] The repressor
will inhibit the RNA polymerase (RNAP) from binding to the promoter whereas an

inducer will promote the binding of RNAP.[12] For instance, the lacI gene is a repressor

in the lac operon.[10, 16-18] In the ara operon, the araC protein functions as both a
repressor and inducer depending on whether arabinose is present in the system.[9, 19, 20]
Both operons will be reviewed in the next sections.

2

1.2 Lactose and the Lac Operon
Lactose, commonly found in milk and other dairy products is termed a

disaccharide because it is composed of a single molecule of glucose with galactose.[17,
21] In 1961, Jacob and Monod proposed the lac operon model for regulating gene
expression based on lactose metabolism in E. coli.[22] This model depicts how genetic
mechanisms can regulate metabolic events in response to environmental stimuli by

coordinating transcription of a cluster of genes with related function. In E. coli, the
genetic circuitry is present to breakdown lactose into its monosaccharide molecules,

glucose and galactose. Lactose has a molecular weight of 342.30 g/mol with a molecular
formula of C12H22O11 and an IUPAC name of 4-O-P-D-galactopyranosyl, Dglucopyranose.

In Escherichia coli, the metabolism and transport of lactose is facilitated by the
lac operon.[14, 23] The lac operon is composed of an operator (lacO), a terminator (not
shown in Figure 1), a promoter (lacP), and the structural genes Z, Y, and A are required
for the uptake and metabolism of lactose. [9] lacY encodes for P-galactoside permease
(LacY), the protein responsible for the transport of lactose into the cell. lacZ encodes P-

galactosidase (LacZ), an enzyme which breaks down lactose into galactose and glucose,
its monosaccharide constituents. lacA encodes P-galactoside transacetylase (LacA), the
enzyme that transports an acetyl group from acetyl-CoA to P-galactosides.
Several factors account for the regulation of the lac operon including the
availability of glucose and lactose.[11, 24] In the absence of lactose as an energy source,

the proteins for catabolism of lactose are not produced.[9, 11, 24] Gene regulation by the

lac operon is most often used as a standard when comparing other systems of gene
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regulation since it is the first to be comprehensively studied and well understood. The lac

system continues to advance our molecular understanding of genetic regulation and the

relationship between, structure, sequence, and function.[22]

Regulator
Gene

Figure 1 Structure of the lac operon.
Republished with permission of American Society for Cell Biology, from Development of a Lac
Operon Concept Inventory (LOCI), K. M. Krafinski et al., Vol. 15, Issue 2, Copyright 2016;
permission conveyed through Copyright Clearance Center, Inc.

An intracellular regulatory protein is essential to for the genetic regulation of
lactose. The gene, lacI, is always expressed.[9, 11, 24, 25] The gene product, LacI, binds

rigidly to the lac operator (lacO) through a DNA sequence downstream of the promoter

in the absence of lactose in the growth medium.[9, 11, 24] When the repressor binds to
the operator, it prevents the binding of RNA polymerase to the promoter. As a result, the

LacY and LacZ gene products are transcribed at low levels. The aforementioned
repression behavior is termed “negative regulation.” [9] Induction of the repressor results

in the synthesis of mRNA, the encoded proteins and enzymatic activity of the lac
structural genes. [22]
In the presence of lactose in the complex media, basal levels of isomerized

lactose, known as allolactose, binds to the repressor protein, LacI, triggers a

conformational change.[9, 11, 24, 26] This permits the RNA polymerase to transcribe the
4

lac genes since the repressor is no longer binding to the operator, thus preventing
repression. Allolactose is considered the true inducer of the lac operon, because once it

binds LacI, the structural genes (Figure 1) are simultaneously switched on and are then
able to express proteins. As the LacZ and LacY gene products are manufactured, their

role is to break down and import lactose. Ultimately, the lacI is released and further
mRNA activity ceases. The residual mRNA in the cell breaks down due to its half-life of

less than 10 minutes.[27]

Another viable option for inducing target protein via the lac promoter is the
chemical agent, isopropyl B-D-thio-galactoside (IPTG), termed classical or standard

induction. IPTG functions as a lactose analog; in contrast to allolactose, IPTG does not
get metabolized.[9] This is beneficial in the sense that the IPTG concentration in the

media remains constant. A disadvantage to using IPTG is the cost; according to
Thermofisher pricing, IPTG is more expensive than lactose or galactose. A 1-gram bottle
of IPTG costs $82.00 and for a 1-kilogram bottle of a-lactose costs $88.40. The price of
D-galacotse is $182.00 for a 100-gram bottle.

1.3 Regulation by Cyclic AMP

As stated before, in the presence of glucose in the complex media, E. coli will
metabolize it before other carbon-energy sources.[13] The enzymes necessary for glucose
metabolism are always present in E. coli. The amount of glucose present in the cells is
inversely proportional to the concentration of cyclic AMP (cAMP).[15, 28, 29] Glucose

prevents the uptake of other sugars by halting the synthesis of cyclic AMP, the messenger

molecule tasked with coordinating carbon and nitrogen utilization, and by inducer
exclusion.[5] In the glucose metabolic pathway, ATP is provided in order to create cAMP
5

by the enzyme adenylate cyclase which is encoded by the cya gene.[5] The cAMP

receptor protein (CCR) or catabolite activator protein (CAP) is encoded by the crp

gene.[5, 12, 15, 18, 29] When glucose is plentiful, the concentration of cAMP is low,

which means that the CAP is not bound, which results in RNA polymerase having poor
binding and therefore making transcription impossible.[30] For transcription to occur,

cAMP must bind to the CAP which binds to the lac promoter. While lactose and glucose
are simultaneously present in the complex media, lactose is not readily metabolized until

P-galactosidase is synthesized. In reverse, while the concentration of glucose is low, the
levels of cAMP increase. Transcription is facilitated when cAMP and CAP bind to the

lac promoter, which in turn enhances the affinity of RNA polymerase for the promoter
(Figure 2).

With glucose and lactose simultaneously present in the complex media, lacI
inhibits lactose from binding to the operator, however, the enzymes used for lactose
metabolism are still synthesized albeit in small quantities.[31] This phenomenon is

termed “leaky” expression or basal expression. In recombinant protein expression

systems, leaky expression is undesired, but some basal expression is essential so a small

amount of lactose is metabolized after glucose is depleted but prior to the full activation
of the lac controlled genes.[12] Synthesizing these essential enzymes used for
metabolism in high quantities results in a delay of log growth phases. [32] Cell cultures

grown in media in the presence of multiple energy sources results in the observation of
multiple log growth phases. “Diauxic” growth is termed when cell cultures contain
multiple log phases with numerous substrates.[5, 33, 34]
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Lactose operon: Absence of lactose
Lactose metabolic genes

Inducer
dissociation

of glucose
ise): Ternary complex formation

low levels of
lacZYA mRNA

Lactose operon: Presence of lactose, absence of glucose

Figure 2 Schematic of the lactose operon.
In the absence of lactose, lacI mRNA is transcribed from the lacPi promoter and translated in
LacI gene product which binds to the operator lacO1. The LacI binding site overlaps the promoter,
which transcribes the structural genes of the lacZ, which encodes p-galactosidase (LacZ); lacY
which encodes lactose permease (LacY); and lacA, which encodes thiogalactoside transacetylase
(LacA) is inhibited. In the presence of lactose, a secondary metabolite, 1,6-allolactose, is
manufactured, which binds to LacI and reduces its affinity for the operator site, which results in
incremental increases of lac metabolic enzymes being produced. If glucose is absent, the CAP
cAMP complex forms and facilitates transcription of the lac structural genes, which results in
large increases in the amounts of lac metabolic enzymes generated. Reprinted by permission from
Springer Nature Customer Service Centre GmbH: Springer Nature, Cellular and Molecular Life
Sciences, The lactose repressor system: paradigms for regulation, allosteric behavior and protein
folding, C. J. Wilson et al., COPYRIGHT 2007.

1.4 Arabinose and the Ara Operon
L-arabinose, a five-carbon monosaccharide, is commonly used as a carbon-energy

source by bacterial hosts. It has a molecular weight of 150.13 g/mol and a molecular
formula of C5H10O5. Sugars are structurally more abundant in nature as D-(+)7

glyceraldehyde also referred to the “D’ form. However, with arabinose, the “L” form is
more abundant in nature.
ne Pc °;

°i

CAP

*1

«a

HibJöHnMe

RtfuMai

lumm»

«¿d

Epimerise

Figure 3 Arabinose Operon of E. coli
Arabinose isomerase (AraA), encoded by araA, converts arabinose to ribulose; ribulokinase
(AraB), encoded by araB, phosphorylates ribulose; ribulose-5-phophate epimerase (AraD),
encoded by araD, converts ribulose-5-phosphate to xylulose-5-phosphate, which can then be
metabolized via the pentose phosphate pathway.[35] The structural genes are arranged in a DNA
loop that is regulated by AraC.[20] Reprinted by permission from Springer Nature Customer
Service Centre GmbH: Springer Nature, Applied Microbiology and Biotechnology,
Corynebacterium glutamicum as a potent biocatalyst for the bioconversion of pentose sugars to
value-added products, Vipin Gopinath et al., COPYRIGHT 2011.
.

The ara operon codes for three structural genes which include: ribulokinase

(AraB) which phosphorylates ribulose, is encoded by araB; arabinose isomerase (AraA),
the enzyme that isomerizes arabinose to ribulose, is encoded by araA; ribulose-5-

phosphate epimerase (AraD), which isomerizes ribulose-5-phosphate to xylulose-5phosphate in order for metabolism via the pentose phosphate pathway, is encoded by

araD (Figure 3).[12, 15, 36, 37] Combined these structural genes are known as araBAD.
The ara operon also contains two promoter sites, PBAD and PC; an inducer site, araI; and
two operator sites, O1 and O2.[16, 38] The three structural genes are arranged into an

operon and regulated by the araC gene (Figure 3). AraC inhibits its own transcription by
binding to both operator sites, O1 and O2 which blocks RNA polymerase from access to

the promoter.[20, 37] This form of autoregulation is known as positive and negative

control, where negative control involves the removal of a restraining element which
allows expression from a high-level promoter, while positive control involves a

stimulatory element which activates expression from a low-level promoter.[8] In the
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presence of arabinose in the media, AraC, is bound in a trans configuration, activates
transcription via the PBAD promoter. At low arabinose levels, transcription of araC
continues until there is sufficient amount of AraC to hinder transcription.[20] AraC

blocks transcription via the PBAD promoter by concurrently binding to the initiator and

operator sites in a trans configuration. Once the arabinose is incorporated into the media,

it binds to the AraC and induces a conformational change from a trans to cis
configuration by allosterically binding to the araI half-site instead of araO2 half-site.

Once the system runs out of glucose, the CRP bound to the araO1 and araI half-sites aids
in uncoupling the DNA looping.[15, 38-41] Figure 4 graphically illustrates gene
expression via the arabinose operon.

Figure 4 Regulatory network of the ara system including the gfp gene.
The system is composed of genes for arabinose metabolism (araBAD), the regulator protein
AraC, and the genes responsible for transporting arabinose (araFGH, araE). [20, 25, 26]
Arabinose induction stimulates expression from the promoters PE, PFGH, and PBAD. AraC inhibits
its own expression from PBAD in the absence of inducer (not shown). In light shading, the mutant
genes for chromosomal araBAD are deleted which removes additional negative feedback. [32]
Plasmid-borne gfp variant under the control of the PBAD promoter is used as a reporter for the
expression of the ara system. [32] This article was published in Biophysical Journal, Vol 95,
Judith A. Megerle et al., Timing and Dynamics of Single Cell Gene Expression in the Arabinose
Utilization System, Pages 2103-2115, Copyright Elsevier 2008.
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Arabinose must be imported from the complex growth medium to the cell’s

cytoplasm to initiate metabolism. The uptake of arabinose is attributed to two transport
genes. The PFGH promoter controls the high affinity transport system araFGH while the

PE promoter controls the low affinity transport system.[25, 26] The transport of the

aforementioned operons exhibit a rapid response of ranging from 15-30 seconds upon
arabinose insertion to have relatively induced levels.[19, 20, 42]

As stated before, the ara operon exhibits both positive and negative
regulation.[37] The ara operon also has different uses for the cAMP receptor protein
(CRP). The cAMP receptor protein in the lac system allows RNA polymerase to bind to

the promoter, while in the ara system it does not. With arabinose present in the cell, CRP

enables the rearrangement of AraC to initiate transcription via the PBAD promoter.[5, 40]

Described as the light-switch mechanism, AraC breaks the DNA looping by simultaneous
binding of the inducer and operator half-sites.[39]

The DNA looping (Figure 5) is generated when the araC gene product, a dimer in

solution, binds to the araI and the araO2 sites.[4, 15, 38-40] It is through DNA looping
that protein saturates at their DNA-binding sites at lower concentration.[30] The

intervening DNA looping sterically hinders the RNA polymerase from accessing the
PBAD promoter site.[38, 41, 43]

The ara system, similar to the lac system is subject to catabolite repression.[12,

29] However, basal expression is minimal with the ara operon.[44] Expression of the ara

operon, similar its lac counterpart, requires a cAMP-CRP complex present.[30] A high
concentration of glucose in the media triggers low levels of cAMP which in turn also
inhibits the ara operon.[12] Due to carbon catabolite repression, the conditions for the

10

arabinose and lactose to be used as energy sources by the cell are similar.[30] As the cells

dedicating their cellular energy to growing, pre-induced expression levels are about 1/300

of post-induction levels.[20]
1.5 DNA Looping
DNA looping is created by a protein or a complex of proteins that bind to two
different sites on a DNA molecule.[4] This phenomenon is central to the regulation of

several biochemical transactions involving DNA, such as the regulation of DNA

replication, the regulation of expression of eukaryotic and prokaryotic genes, and the
regulation of site-specific recombination.[4]

The monomer consists of two domains, a DNA-binding domain and a
dimerization domain that binds arabinose (Figure 5a). The domains are lightly connected

to a flexible linger that allows a dimeric protein to bind to half-sites and permits a protein
to bind to inverted half-sites. In the absence of arabinose, the N-terminal arm extends
from the dimerization domain and binds to the side of the DNA-binding domain.[20]

Collectively, the arm and the linker holds each DNA-binding domain rigidly to its

dimerization domain. The DNA-binding domains are oriented to the I1 and O2 half-sites

and forms a DNA loop (Figure 5b). Binding in a cis conformation (adjacent half-sites)

would require breaking at least one DNA-binding domain interactions or significant
curving of the AraC; therefore, it is energetically unfavorable for AraC to cis-bind to I1-I2

in the absence of arabinose, but energetically favorable for AraC to bind in a trans
conformation to nonadjacent half-sites to form a DNA loop.[20] As arabinose binds to
the dimerization domains, it becomes more energetically favorable for the N-terminal
arms of the AraC to bind to the dimerization domains (binding cis) than to the DNA11

binding domains (Figure 5c). The arms are then free to reorient and form a relative

orientation since their interactions with the DNA-binding domains relaxes the constraints
holding them. The now flexible AraC allows the overall energy of the DNA-AraC system

to be lower so AraC binds to the I1 and I2 sister sites rather than loop between I1 and

O2.[20]
The DNA loop formed in the absence of arabinose achieves many things for the
arabinose system. First, its existence sterically blocks the RNA polymerase from access

to the pBAD promoter, which holds basal levels of pBAD to low levels. The loops also

blocks the RNA polymerase from accessing the pC promoter and potentially hinder the
binding of cyclic AMP receptor protein to its binding site next to the AraC. Looping to

O2 keeps the AraC from occupying the I2 half-site and improperly activating transcription
from pBAD. Lastly, AraC binding to the regulatory region in the absence of arabinose

enables it to respond very quickly to the addition of arabinose as the potentially slow

DNA-binding step has already taken place.[20]
In summation, some differences between the ara and lac expression systems are:
•

AraC represses its own transcription;

•

AraC acts as an activator or repressor in the presence or absence of arabinose
respectively;

•

the ara system is regulated by DNA looping;

•

the lac system is regulated by lacI;

•

the lac system exhibits “leaky” expression
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Figure 5 Regulation of the L-arabinose operon by arabinose.
The domain structure of a dimeric AraC subunit (a) the PBAD and PC regulatory regions in the
absence (b) and presence (c) of arabinose. In the absence of arabinose, RNA polymerase is
sterically hindered from accessing PBAD and PC. The cyclic AMP receptor protein (CRP) is
hindered from accessing the DNA site. In the presence of arabinose, AraC binds to the adjacent
sister sites I1 and I2 instead of looping. RNA polymerase and CRP are then free to bind to PBAD.
[20] Reprinted from Trends in Genetics, Vol 16 Issue 12, Robert Schleif, Regulation of the Larabinose operon of Escherichia coli, Pages 559-565., Copyright 2000, with permission from
Elsevier.
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1.6 Auto-induction
Previously stated, an inducible system is never on except in the presence of an
inducing agent that stimulates protein synthesis. Protein expression is initiated when
metabolism is shifted from cellular growth to protein production, cellular growth rates

decrease or in some cases stay constant. Usually, induction occurs after the cells are
grown to a desired concentration and the inducing agent is added. In some instances, the

changing culture conditions also induces the desired protein.
A classical method of protein expression comprises of the lac operon in BL21, a
commonly used E. coli strain, in tandem with the addition of IPTG to stimulate bacterial
protein expression.[18, 44-47] Typically, bacterial cultures are grown to mid-log phase,

and at certain cellular concentration are induced by the supplementing the media with
IPTG, which activates transcription. In order to avoid saturation of the cell cultures
before induction, cell cultures are regularly monitored. Upon induction, cellular growth
slows as the cellular energy is repurposed for protein production under the control of the

T7 promoter. A drawback on this system is that the plasmids transformed into BL21 cells
are unstable when grown in LB growth media. To address this drawback, Dr. Studier and

his colleagues established customized growth medium that led to the auto-induction
methods currently employed in many research labs.[48]
Auto-induction is the special case where the growth media contains two different

carbon-energy sources (glucose and lactose), and the inducible promoter is switched on

automatically once all the glucose is consumed.[48] Lactose present in the media would
induce the cells, however, in the presence of glucose, induction by lactose is inhibited.
Glucose causes low levels of cAMP which prompts carbon catabolite repression.[5] As

14

stated previously, glucose is the preferred carbon source for E. coli, so it is consumed
first as its transported into the cells. Lactose is transported to the cells once glucose is

depleted, which induces the cells. In the lac system, expression via T7 RNA polymerase

is induced in the late log-phase growth, once glucose is consumed and metabolism is
taken up by lactose which becomes the sole carbon source.[30] This procedure
circumvents the addition of IPTG, which more expensive than lactose. Protein expression

via autoinduction eliminates the need for frequent monitoring of the cell cultures; and
recombinant protein expression can occur unsupervised from inoculation to cell

harvesting.[7] This technique has allegedly led to higher cell densities and higher levels

of protein yield. This technique has been implemented in protocols using commercially
available recombinant protein expression systems. An example, Thermofisher’s pET

(plasmid Expression in_T7) expression vectors use the T7 expression system commonly
used for auto-induction. Auto-induction media is also commercially available, e.g.

Formedium’s Auto-induction media (AIM) used with Luria-Bertani medium, lysogeny
broth (LB), Luria broth, Super Broth (SB), Tryptone Broth (YT), and Terrific Broth (TB).

1.7 Green Fluorescent Protein
Green fluorescent protein (GFP) was used as a biological marker in these studies.

The GFP gene was isolated from the bioluminescent jellyfish species, Aequorea Victoria.
GFP is composed of 238 amino acids and has a molecular weight of 27 kDa, is fairly
stable, and does not require any substrates or cofactors.[49] The GFP spectrum has a

minor absorption peak at 470 nm, a major peak at 395 nm and exhibits green
fluorescence at 509 nm.[50] GFP can also be expressed in both eukaryotic and
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prokaryotic cells and is capable of emitting a green fluorescence which is visually

confirmed when excited by UV light. [30, 49, 50]
The GFP gene has been expressed and inserted into various organisms which
include bacteria, mammalian cells, plants, insects, fungi, and human cells.[30] An

application of GFP as a biological marker is used for quantifying, on-line and real time
indicator for recombinant bioprocessing in numerous organisms, most importantly by

exploiting the fluorescent characteristics of the GFP-fusion protein in E. coli.[51] GFP
expression in E. coli, under the control of the T7 promoter yields green fluorescence that

is not noted in control bacteria and is visually observed under a UV lamp.[49]

1.8 All or nothing expression
If high levels of protein synthesis are desired, then all cells in the population must
be induced at maximum levels; for other applications, intermediate levels of expression
are desired, in order to minimize the metabolic burden on the host.[30] In some instances,

it may be more optimal to have little-to-no expression prior to induction, and in the
presence of inducer, controlled expression that preferably varies linearly with the inducer
levels.[46] The ability to modulate protein expression over several orders of magnitude
by using a wide range of inducer concentrations is common in vectors containing both the

ara and the lac controlled-genes.[19]
Low-level gene expression of wild type ara and lac is not representative of a

uniform cellular population of low expressing cells; it characterizes a heterologous
cellular population.[30] Over 50 years ago, studies were conducted to explore the
expression of the lac operon in the presence of non-saturating induction levels (below

what is needed for maximal induction).[52] The results displayed that the majority of the
16

cells in the population remain uninduced while only a fraction were induced. Also, a
direct relationship between the fully induced cells and the inducer concentration was
established. However, the response of the araC-PBAD system in individual cells to inducer

concentrations exhibited a nonlinear relationship.[53] Expression systems that exhibit allor-nothing expression contain the essential genes that encode for the transporter under the
control of the inducer. This autocatalytic process is known as “all-or-none” gene

expression. Once exposed to the inducer, the inducer is transported into the cell by a
minimal number of transport proteins in the membrane. As inducer levels accumulate

within the membrane, any transporter genes and other associated genes become induced.

As more transporter genes accumulate and higher levels of inducer are imported, the
system rapidly cascades to maximal gene expression.[53] In E. coli, some expression

systems are known to demonstrate all-or-nothing induction of expression.[54]
Gene expression at low inducer concentrations coming from plasmids that contain
the araBAD promoter display all-or-nothing expression.[55, 56] Under non-saturating

levels of inducer concentration, some cells remain uninduced while the other cells in the
population are fully induced.[32] Plasmid vectors have been modified to exclusively

carry the PBAD and araC gene segments from the ara operon, thus eliminating the
transport genes. These plasmids have been successfully cloned into E. coli based

competent cells.[19] This self-regulating system exhibits fine control of gene expression,
induction over 1,000-fold range with arabinose present and tight repression in the
absence of arabinose.[53] Expression can also be modulated with the ara promoter to

allow rapid turning off and on of protein synthesis.[19, 55]
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In most cases, as induction levels are identifiable where high level protein

synthesis is induced in all cells, all-or-nothing expression becomes irrelevant. When

regulated low-level expression is preferred, the transport gene is constructed and
independently regulated from the inducer. In order to decouple autocatalytic systems, one

strategy is to use a plasmid with a cloned independently regulated transport gene.

Homogeneous expression can occur when a mutant lactose transporter enables diffusion

of arabinose.[57] Another strategy involves using an inducer analog that does not require
transport protein that can diffuse across the cell membrane. For instance, the vectors

carrying IPTG-inducible Ptaclac or Ptac promoter to regulate the araE transport protein
are ideal.[53]

1.9 Batch Fermentation
In batch fermentation, sterile nutrient growth media is inoculated with a seed

culture, then the organisms selectively uptake the dissolved nutrients from the media to

convert into biomass.[34] The operating conditions take place under a well-mixed and
aerobic system.[58] Following the fermentation process, the cells are harvested for

downstream processing. In between the life cycle, the cells initially enter a lag phase
where bacteria acclimate to the new environment, followed by the exponential phase
where the biomass concentration increases steadily (optimal growth is observed here),

then a stationary phase where essential nutrients and substrates are depleting (bacterial
growth is neither rising nor decreasing), and ends with the death phase where the cells

lyse and the net growth of biomass decreases (Figure 6).[33, 34, 58] Cells from the starter

cultures may have entered the stationary phase in which cells have ceased growth due to

product inhibition or substrate limitations.[30] Therefore, immediately after inoculation
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microorganisms reorganize their molecular constituents when switched to new sterile

media so a lag phase occurs while cells acclimate to the new environment.[30, 34] Upon
inoculation, some new enzymes and metabolic pathways may be synthesized as the
internal machinery of cells is adapted to the introduction of new growth media.[10, 34]

Therefore, under ideal conditions, an inoculated cell culture may display minimal lag
growth when introduced to the same but fresh sterile growth media.[10]

Figure 6 Typical growth curve for a batch system.
Reprinted by permission from Springer Nature Customer Service Centre GmbH: Springer Nature,
Springer eBook, Modeling Applications in Environmental Bioremediation Studies, Mahmoud
Nasr, COPYRIGHT 2018.

The growth rate of the cell culture is a function of the limiting substrate
concentration under no product inhibition and excess nutrients.[33] In a batch

fermentation, the governing equations are:
dX
at = k*

|1 =

|lmax(—)

Ks+S'
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Where the values denote:
— - biomass growth rate (mg L-1 d-1)
X - concentration (mg L-1)

H - specific growth rate constant (d-1)
|lmax — maximum specific growth rate (d-1)
KS - half saturation constant (mg L-1)

S - limiting substrate concentration (mg L-1)

Cells grown in batch fermentation are harvested in late log phase for protein

production.[59] In the stationary phase, metabolic products can accumulate to high levels
that are potentially toxic to the cells. High levels of metabolic products can also inhibit

cellular growth. As the stationary phase advances, microorganisms may synthesize

proteases that degrade protein.[60] This part of the batch cycle is avoided since by this
point, there are fewer cell resources available to continue protein production and a

fraction of the amount of energy available is only supporting it. With limited exceptions,

cell harvesting later in the log phase will lead to protein degradation which will lower

protein yield.[30, 61]
1.10 High cell density culture media formulation
The main objective of batch fermentation is optimizing purified product while
minimizing time.[30] To grow cells to a high cell density for high productivity, it is
necessary to design an optimized growth media that contain all the necessary nutrients,

while avoiding inhibition.[62, 63] However, the media itself presents limitations. For

example, ammonia concentrations above 3 mg/L is inhibitory, phosphorous inhibits
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cellular growth above 10 mg/L, while glucose inhibits cell growth above 50 mg/L. As a

result, starting material for high cell density cultures are started at concentrations below
inhibition thresholds and nutrients are added accordingly to sustain high growth rates.[62]

Complex media nutrients such as tryptone and yeast extract can vary in quality
and composition which may result in fermentation from these complex media as less

reproducible.[30, 62] Formulated high density growth media is necessary to achieve high
density cellular growth. In a shaker flask under aerobic conditions, TB media can support
cellular growth to a cell density of OD600 of 9 while LB media can grow cells to an OD600

of 3 (unpublished data). Proprietary media from Studier’s media recipes can support
cellular growth to higher cell density.[48] In an industrial fed-batch system, cell densities

of an OD600 of 100 upon harvesting have been reported for production of bovine
somatotropin.[62]

An advantage to using complex media containing yeast extract provides numerous

amino acids, trace metals, and vitamins that are unavailable in simple media.[64] An
abundance of yeast extract is beneficial in suppressing protein degradation of expressed

recombinant protein.[65] In some cases, glycerol is preferred over glucose as a carbon

source in high cell density culture media because there is little concern for the catabolite
repression of Parab and it is readily sterilizable combined with a nitrogen source.[64] Cell

cultures grown in the presence of excess glucose under anaerobic conditions leads to the

formation of acetate which reduces biomass yield, maximum attainable cell densities, and
growth rate; however, using glycerol is advantageous for controlling the accumulation of

acetic acid.[62, 64]
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The pH plays a significant role in bacterial expression especially for high cell
density cultures and for growth rates. The organism can metabolize sugars such as
glycerol and glucose to use as energy sources. When sugars are utilized as energy
sources, acetic acid is produced which lowers the pH.[24] Oxygen- limiting or low

aeration also contributes to the production of acidic conditions in the media. Metabolism
of glucose for instance, can trigger acidic conditions which overwhelm the buffer present
in the media during fermentation. E. coli can grow optimally at near neutral pH but also
grow at a minimum and maximum pH of 4.4 and 9.0 respectively. Phosphate salts are

commonly used to buffer the media to maintain the pH at near neutral. At high cell
density (OD600 > 10) the phosphate buffer capacity is exhausted.[47] Fed batch media
will regulate pH by either limiting glucose addition or adding buffer components to the

media.[30]
1.11 Vibrio natriegens

Vibrio natriegens, although first described in 1958, has very few studies so
far.[66] Vibrio natriegens is a Gram-negative, marine halophilic nonpathogenic organism
from the family Vibrionaceae.[67] Currently, V. natriegens has the fastest growth rate of

any nonpathogenic organism with a doubling time of < 10 minutes, whereas, E. coli has a
doubling time of 20 minutes.[66] V. natriegens remarkable doubling time is attributed to

increases in its number of ribosomes with the growth rate to fuel its extremely high rate

of protein synthesis.[68] Due to its short generation time, V. natriegens is being exploited
as a fast-growing host for molecular biology, to provide genetic engineering tools for
targeted metabolism and modification.[21] With a higher protein synthesis rate the

RNA/protein ratios will be higher in V. natriegens than in E. coli for a given growth rate,
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so V. natriegens produces less protein per unit rRNA than E. coli, which means in this

bacterium more ribosomes are needed to make the same amount of protein as E. coli.[68]

Therefore, V. natriegens meets its need for a higher rate of protein synthesis, not by
ribosomes translating faster, but by increasing the ribosome number to a level far higher
than E. coli to provide the high rate of protein synthesis required for short generation
times.

Four inducible promoters were found to function in V. natriegens which include:
the phage 1 pR promoter regulated by cI857 (temperature inducible), the lacUV5 and trc

promoters regulated by lacI (IPTG inducible), and the araBAD promoter regulated by
araC (arabinose inducible).[66] V. natriegens, also formerly known as Beneckea

natriegens before the species was transferred to the genus Vibrio, has the ability to utilize

a wide range of carbon-energy sources, which include: DL-alanine, cellobiose, ethanol,
D-galactose, glycine, L-histidine, D-mannitol, L-ornithine HCL, propanol, L-serine,

sodium acetate, sodium butyrate, sodium caprylate, sodium citrate, dosium gluconate,
sodium glutamate, sodium malate, sodium pelargonate, sodium propionate, sodium
valerate, sucrose, L-threonine, and L-tyrosine.[69]
V. natriegens has similar carbon metabolism and amino acid biosynthetic

pathways as E. coli which includes the following core metabolic pathways: pentose
phosphate pathway, TCA cycle, glyoxylate shunt, glycolysis (EMP pathway), EntnerDoudoroff pathway, and several cataplerotic and anaplerotic reactions.[70] V. natriegens,

has an additional cataplerotic reaction, oxaloacetate decarboxylase which is not present in
E. coli.[70] The overall carbon balance between V. natriegens and E. coli was similar,

nearly 50% glucose converted to biomass, 25% to acetate and 25% to CO2.[70] V.
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natriegens has been observed to fix atmospheric nitrogen when batch cultures are shifted
from aerobic N-replete to anaerobic N-replete conditions; however, unlike other N2 fixing

heterotropic bacteria, the nitrogenase enzyme must be resynthesized in V. natriegens after

aerobic exposure.[71] This may someday play an important role in supplying nitrogen in

marine ecosystems.

A desired trait of a protein-production organism is the ability to directly secrete
proteins into the growth media, as this decreases the time and expense related to
downstream processing. V. natriegens batch cultures grown in the presence of sucrose as
the carbon-energy source were observed to secrete several proteins at high

concentrations.[66] Collectively altogether, these traits render V. natriegens an attractive
organism for future biotechnological applications. The prospect of higher overall

production, which is a requirement for microbial fermentation processes to produce
commodities allows V. natriegens to function competitively with existing petrochemical
approaches.[21] Also, it can speed up common laboratory procedures, is suitable for

currently used production protocols and forms an excellent foundation to engineer next

generation bioprocesses.[21]
1.12 Motivation
The objectives of this project were to optimize production of elastin-like-

polypeptides (ELPs) by targeting the bacterial host, expression systems, inducers, and
resistance markers. ELPs are stimuli responsive biopolymers with applications as

hydrogel scaffolds for tissue engineering, as drug delivery systems, and as purification
tags for recombinant proteins.[72] ELPs exhibit inverse transition temperature (Tt)

cycling. Below the Tt, the polypeptide is soluble; above the Tt, the protein isolates into
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two phases: a protein rich insoluble phase and a protein poor soluble phase.[73] Phase

transitions can also be attributed to other stimuli such as, pH, ionic strength, and light.

[74] The fundamental structure of ELPs consists of pentapeptide repeat sequence
Glycine-Valine-Glycine-Valine-Proline (GVGVP).[72]

An ELP with 37 pentapeptide repeats, (GVGVP)37, which was tagged with a GFP

insert to function as a biological marker for protein expression, was utilized for this
project. The same ELP-GFP fusion protein, was inserted into different vectors, one with
the lac promoter and another with the araBAD promoter. The vectors were constructed

with one of the resistance markers, ampicillin or kanamycin, to make a total of four

different plasmids (Table I). All four plasmids were transformed into BL21 (DE3), to
compare the fluorescence levels of the ELP-GFP fusion protein with variable phenotypes.

The ELP-GFP fusion protein in this study will be called “GFP-37R” to denote it is a GFP

with 37 pentapeptide repeats. An ELP-GFP fusion with 73 pentapeptide repeats,

(GVGVP)73, GFP-73, was used to evaluate protein expression levels between BL21
(DE3) and Vmax, due to unsuccessful transformations of GFP-37R plasmids into Vmax.
By investigating the aforementioned variables and optimizing protein expression of ELPGFP fusion proteins, we will have a better idea how to maximize protein expression of

ELPs. The GFP tag will allow us to understand the behavior of the protein during the

fermentation steps. Aside from fluorescence, the protein is visibly green which will also

allow us to effectively purify. Non GFP-tagged proteins almost always need to be

purified in order to find out the protein yields at the end. With the GFP tag, we are able to
determine the best times to harvest the cells and find out the peak production times.
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CHAPTER II

MATERIALS AND METHODS

2.1 Expression Strains
All plasmids described here were transformed into the E. coli strain BL21 (DE3),

and/or the Vibrio natriegens strain, Vmax. BL21 (DE3) can transport arabinose,
galactose, and lactose, but is unable to metabolize IPTG and galactose, whereas Vmax is
able to transport arabinose and unable to metabolize IPTG. All plasmids containing the

ampicillin resistance were transformed into Vmax, but only the vector p4E9, a GFP

fusion with 73 (GVGVP) pentapeptide repeats (Figure 7) was successful. For these
studies, GFP protein that contains the plasmid p4E9 will be called “GFP-73” to denote it

is a GFP with 73 pentapeptide repeats. The other plasmids contain 37 (GVGVP)
pentapeptide repeats and for these studies, the protein will be denoted as “GFP-37R.” The

major difference between the strains is BL21 (DE3) has the lac operons which breaks
down lactose while Vmax lacks that genetic circuitry, so autoinduction with lactose or

galactose will not be possible with Vmax. However, the lacUV5 and araBAD promoters
are present in the V. natriegens genomic structure so depending on which vector is

present, V. nagtriegens is IPTG and arabinose inducible.[66]
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Selection of colonies from p4E9, p5A2, and p5A4 (see Figure 7) in Luria Bertani-

agar (LB-agar) plates, LB-Miller agar for Vmax, were selected via induction with 0.05%
arabinose. These plasmids contain the araBAD promoter, which is more restrictive than
the lac system, hence induction is needed to distinguish between background colonies

and induced colonies. The induced colonies were visibly green under a UV light source
when grown in LB-agar plates containing the selective resistance from the plasmid

resistance marker, and arabinose. Background colonies displayed no fluorescence and
were avoided for making frozen stocks. The colonies for p4E9, under the Vmax strain
were visibly fluorescent but not as intense as its BL21 (DE3) counterpart. In the absence

of arabinose, the colonies from the previously mentioned plasmids are uniformly dark
under UV illumination. Fluorescent colonies were inoculated in 5 mL of LB media for
BL21 (DE3) and 5 mL of LB-Miller supplemented with V2 salts for Vmax and grown

overnight at 37°C and 30°C, respectively. Frozen stocks of the seed cultures were made
by inoculating 1 mL of culture with 1 mL of 50% (v/v) glycerol in flash freezing
conditions in an ethanol and carbon dioxide dry ice bath to prevent ice crystals from
shearing the cultures and stored at -80°C. The remaining cell cultures can be harvested

for DNA purifications should more plasmid be needed later. The plates that contain
fluorescent colonies were refrigerated to prevent the colonies from overgrowing. In my
experiments, overnight cultures were prepared from frozen stocks, however, overnight

cultures can also be prepared from fluorescent colonies.
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Figure 7 The arabinose inducible plasmids.
The plasmid p4E9 contains 73 (GVGVP) repeats whereas plasmids p5A2 and p5A4 contain 37
(GVGVP) repeats. The plasmids p5A2 and p4E9 have the ampicillin resistance gene while p5A4
has the kanamycin resistance gene. All cell cultures were transformed into BL21 (DE3) while
only p4E9 was the only successful transformation into Vmax. All cultures are L-arabinose
inducible. All plasmids contain the superfolder GFP gene as a biological marker for protein
expression.

Colonies from p5A3 and p5A5, which contain the lac-controlled genes grown in

Luria-Bertani medium with ampicillin and kanamycin as selective agents, respectively,
do not require inducer present on the agar plates to glow bright green under illumination

of a UV light source, since the lac system is said to experience “leaky expression”
(Figure 8).
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Figure 8 The plasmids containing the lac operon.
All vectors are regulated by lacI and inducible with IPTG, lactose, or galactose. However,
plasmid p5A3 has the ampicillin resistance tag whereas p5A5 has the kanamycin resistance tag.
The aforementioned plasmids contain 37 (GVGVP) repeats and carry the superfolder GFP gene
to function as a biological marker for protein expression.

Table I Expression Vectors
Vector
p4E9
p5A2
p5A3
p5A4
p5A5

Resistance
Ampicillin
Ampicillin
Ampicillin
Kanamycin
Kanamycin

Regulator
araC
araC
lacI
araC
lacI

2.2 Expression Vectors
The plasmids consist of fusion proteins consisting of elastin-like polypeptides
(ELP) and green fluorescent proteins (GFP). ELPs are temperature responsive
biopolymers that form thermo-reversible aggregates at certain temperatures.[75] The

vector p4E9 has 73 (GVGVP) pentapeptide repeats whereas the p5 variants have 37
(GVGVP) repeats. G is glycine, V is valine, and P is proline.[75] The GFP tag is intended
to function as a reporter for protein expression. Due to the low efficiency of transforming

plasmids into Vmax via chemically competent cells, only p4E9 was successfully
transformed so it will be included in this study only to compare protein expression
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between Vmax and BL21 (DE3). Also, since V. natriegens has a natural resistance to

kanamycin, plasmids containing kanamycin as the selective agent were excluded in
Vmax transformations.

2.3 Media Formulations
Unless otherwise noted, all chemicals and reagents were purchased from
Thermofisher. The defined media listed here were used in one or more protein

expressions and serve as the basis for media formulations for lac and ara expressions in
BL21 (DE3) (Table II). For Vmax the formulations were somewhat different since Vmax

is a marine halophilic host that requires high salt concentration to thrive (Table III). All
media contained 100 |ig/mL of ampicillin or 50 |ig/mL of kanamycin depending on the
selectable marker of the expression plasmid.

Table III Typical media used for Vibrio
natriegens.

Table II Typical Media Used for
Escherichia. coli.
Medium

Recipe (IL)

Medium

Recipe (IL)

Low Sodium LB
(Luria-Bertani)

10 g Peptone
5 g Yeast Extract

LB-Miller

10 g Tryptone
5 g Yeast Extract

5 g NaCl

5 g NaCl

Terrifie Broth
(TB)

Enhanced 2xYT

12 g Tryptone

20 g Tryptone
32g Yeast Extract
17 g NaCl

24 g Yeast Extract
0.15 gMgSOi

3.30g(NH4)2SO4

17mM(NH4)2SO4

6.50 gKHsPO4

0.2% glucose

7.10 gNaaHPCM

pH adjusted to 7.4

V2 salts

0.50 g glucose
pH - 7.4

204 mM NaCl

4.2^^
23.14 mMMgCh
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The V2 salts were filter sterilized since autoclaving MgCl2 forms a white
precipitate that does not form if it is filter sterilized.

2.4 Chemical Additions
2.4.1 Arabinose
L-arabinose is the inducer of the ara operon. Arabinose stock solutions were

prepared at 0.05% (w/v) and 0.2%. Afterwards stock solutions were filter sterilized into a
sterilized bottle and stored in the refrigerator at 4°C.

2.4.2 Glucose
D-glucose is the preferred carbon-energy source for E. coli and was also used in

media formulations for V. natriegens. Glucose serves to inhibit the lac and ara operons
while simultaneously allowing fast cellular growth. Glucose stock solutions were

prepared at 0.05% for BL21 growth media and 0.2% for Vmax growth media Enhanced

2xYT. Afterwards glucose was filter sterilized and stored at refrigerator temperatures of
4°C.

2.4.3 IPTG
In our lab, 1 mM IPTG is added to cultures grown in LB and TB media to induce

and switch from cellular growth to protein production. Since there is no active transport
for IPTG in the lac operon, induction is immediate and is not metabolized.

2.4.4 Lactose
a-lactose is a precursor to allolactose, the true inducer of the lac operon. a-lactose

is isomerized by the lac-controlled genes once the system is depleted of glucose and
metabolism is switched from glucose to lactose. Lactose stock solutions prepared at
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0.2%. Afterwards, stock solutions were filter sterilized and stored in the refrigerator at
4°C. Induction with lactose is commonly known as autoinduction.

2.4.5 Galactose
D-galactose can be a substitute for a-lactose when doing an autoinduction

experiment. For autoinduction in BL21 (DE3), expression hosts concentrate galactose in
the absence of glucose but cannot metabolize it for lack of galactokinase. Galactose,
unlike IPTG, has an active transporter and is a weaker inducer than IPTG since it does

not bind lacI as tightly as IPTG or lactose but is as efficient as lactose. Galactose stock

solutions were prepared at 0.1% and were filter sterilized then stored in the refrigerator at
4°C.

2.5 Protein Expression
Starter cultures in BL21 (DE3) were grown overnight from 12-16 hours in 15 mL
culture tubes at 37°C moving at 200 RPM on a benchtop incubator. Starter cultures in

Vmax were also grown overnight from 12-16 hours but at 30°C in 15 mL culture tubes
rotating at 200 RPM.

For BL21 (DE3), volumes of 125mL and 1L fermentation batches were used to

accommodate the 50% flask volume usually recommended for protein expression;
however, for Vmax, 400 mL batch volumes in a 2 L flask were used to satisfy the 20%
flask volume or lower recommendation. Since V. natriegens has a fast growth rate and a

very high O2 uptake rate, demand must be satisfied, or the aeration becomes the limiting

factor and will lead to slower growth rates for V. natriegens and ultimately poor protein
production.
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For both bacterial hosts, optimal temperatures were at 37°C and for the volumes

of 400 mL and 1L for V. natriegens and E. coli, respectively, orbital shaker speeds of 200
RPM provided sufficient aeration, bubbling of the media was visually observed on both
hosts. When downscaling to 125 mL in a 250 mL flask, the temperature stayed fixed at
37°C but the shaker speed was increased to 235 RPM to allow for appropriate aeration.

Protein expression for Vmax in 20% flask volume for a 250 mL flask was inconvenient
since 50 mL was not enough sample to work with and often times coagulation was

observed so Vmax expressions increased to 400 mL batch volume to allow adequate

aeration and sample collection.
Throughout the course of the fermentations, 1 mL samples were pipetted from the
shake flasks, OD600 measurements were taken, centrifuged at 7000 rcf for 5 minutes,

decanted so only the fluorescent pellets remained and frozen at -80°C to be further
analyzed for fluorescence and SDS-Page analysis. Prior to centrifuging, OD600 dilutions
were measured for every sample taken to determine the linear cell density of the samples.

2.6 Protein Purification
For analysis of protein expression in both 1 mL samples collected from 125 mL
and 1 L expression volumes, the frozen cell cultures were thawed and mixed with lysis
solution to obtain a final sample composition of 1 mL B-Per II, 2 |iL of lysozyme, and 2
|iL of DNase I. 70 |iL of lysis solution was deposited into each culture collected during

protein expression and thoroughly mixed and vortex. After sitting in lysis solution for 10
minutes, the resulting samples were centrifuged at 4°C and spun at 15,000 rcf. The

soluble fractions were pipetted into 0.5 mL microcentrifuge tubes to be used for
fluorescence spectroscopy and SDS-Page.
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For analysis of 1 L batch, the larger cell pellets in the centrifuge jars were thawed
and scooped into 50 mL centrifuge tubes where they were mixed with 32 mL of PBS
solution and placed on an ice bath to keep the protein from overheating. Afterwards, the

cells were disrupted via sonication using a 550 Sonic Dismembrator (Figure 9) and
protein purification proceeded via thermocycling. Unless otherwise stated, all cold cycles

were done at 4°C and 10,000 rcf and all hot cycles were done at 40°C at 11,000 rcf. A
series of 10 second ON cycles and 20 second OFF cycles were used for sonication. For 1

L batch volume, the sonication process is necessary to break the cell membrane thus
releasing the protein. In some cases, multiple sonication steps may be needed to ensure

all the cells are disrupted. Since it is a GFP fusion protein, the solution is visibly green

and fluoresces when placed on UV light.

Figure 9 550 Sonic Dismembrator used for cellular disruption.

34

The resulting solution is then run on a cold cycle at 4°C and 10,000 rcf (see Table
IV for protein purification steps). Afterwards, the supernatant is decanted into a separate

50 mL centrifuge tube and placed at 60°C in an incubator. The first cold pellet is waste

and may be stored in the fridge for analysis with an SDS-PAGE. Once in the incubator,
the solution turned turbid, indicating a precipitation of other proteins, while still
maintaining the green appearance. After a few hours of visible turbidity, the solution is
run on a hot cycle at 40°C and the soluble fraction is once again isolated from the
insoluble fraction. To make the GFP fusion insoluble, the resulting soluble fraction must

be treated with 2M (NH4)2SO4 and heated at 60°C until visible phase isolation is

observed. Then a second hot cycle under the same settings is run and this time the protein
is in the insoluble fraction. Once again, the supernatant is discarded, and the resulting
pellet is resuspended in 5 mL of PBS and vortex mixed so the pellet goes into solution.
To improve the solubility, the solution is kept in an ice bath while vortex mixing

sporadically. Once the pellet is fully dissolved and maintained cold, a second cold cycle

is done at previous settings. The protein purification process is continued with an

additional hot and cold cycles to eliminate any dense wastes that may still be present in
the solution. The purified protein is then forced through a syringe filter to remove any

impurities. At this stage, the purified protein is ready to be quantified to measure protein

concentration and calculate yield.
Table IV Thermocycling Steps for Protein Purification of a GFP-fusion protein.
Protein
Cycle
Salt Added
None
Cold
Soluble
Hot
Soluble
None
Hot
Insoluble
2M (NH4)2SO4
Cold
Soluble
None
Hot
Insoluble
2M (NH4)2SO4
Cold
Soluble
None
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At some point in the research, it was noted that the protein purification steps

followed in Table IV would lead to protein loss during the hot cycles so an alternative
protein purification pathway was established (see Table V). All the hot cycles except for

one were substituted with cold cycles. In the hot cycles, possibly due to the amount of
protein, there was never 100% GFP coming out of solution, except when applied in the
cold cycles. During the hot cycles, when it was observed that some protein remains in the

soluble fraction, a cold cycle was applied to make it insoluble then it was recombined
with the insoluble fraction from the previous hot cycle. However, this is not
recommended due to being unable to separate any additional cell debris, so changes were

applied towards the end of the research studies.

Table V An alternate Protein Purification method for GFP fusion proteins.
Protein
Cycle
Salt Added
None
Cold
Soluble
Hot
Soluble
None
Cold
Insoluble
2M (NH4)2SO4
Cold
Soluble
None
Cold
Insoluble
2M (NH4)2SO4
Cold
Soluble
None

2.7 Characterization
2.7.1 Cell Growth
Optical density at 600 nm (OD600) is often used to measure the cell density of the

organism being expressed. The OD600 value is also used to determine when to induce
target protein, when the bacterial cells are ready for making competent cells, frozen

stocks or if the cells are ready for harvesting. An OD600 of 1 equates to 1 x 109 cells per 1

mL of culture which can also aid in calculating the bacterial cell weight. [30] The cell
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wet weight is measured by the cell pellet weight generated after centrifuging the cell
culture and discarding the supernatant. [30]

The optical densities were measured using the Thermo Scientific Biomate 3
Spectrophotometer, under the settings for cell growth. An initial 1 mL media sample was

poured on a cuvette with 1 cm path length was used to create a zero-absorbance reference
point, known as a blank. Then subsequent measurements are taken to determine the raw

values for OD600.When checking the optical density using the Biomate 3, after a
measured value of OD600 = 0.45, the OD600 vs concentration curve is no longer linear as it

enters the logarithmic phase, so a series of dilutions are prepared to determine the linear
optical density by pipette mixing sample culture with clean growth media (Table VI).

When doing multiple expressions with different growth media, have separate blanks and

media to use for blanking the spectrophotometer and for dilutions to ensure accurate

results.

Table VI Dilutions to calculate optical density.
Culture (^L)
OD600
0.44-.6
500
250
.61-.99
1-1.45
100
50
1.5-1.75
40
1.8-1.9
20
>1.9

Media (^L)
500
750
900
950
960
980

Multiplier
2
4
10
20
25
50

2.7.2 Quantification
After complete purification, samples are prepared for characterization. The first

characterization performed is a concentration study. Protein concentration is determined
by the solutions based on the molarity of the protein present in the sample. Similar to cell

growth, an absorbance measurement is used to calculate the absorbance of known
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quantity of the protein but at 280 nm. The Beer-Lambert Law is used to calculate the

protein concentration from absorbance. A 1900 |iL sample of PBS or RO water is placed
on a cuvette and used as a zero-absorbance reference measurement in the

spectrophotometer. On this setting, a 280 nm laser goes through the sample to measure
the absorbance in the protein. After creating a reference point, a dilution is prepared by

adding 100 uL of protein with the 1900 uL of solvent already present and pipette mixed
to allow the sample to diffuse into the solvent. This solution is a 20-fold dilution of the

protein. The diluted sample is placed in the spectrophotometer and the absorbance is
measured which will aid in calculating the protein concentration using the Beer-Lambert
Law:

A1280 = slc

Where the values denote:
A1280 - Absorbance at a wavelength of 280 nm

s - Extinction coefficient

l - Solution path length
c - concentration of solution

The extinction coefficient used in this study is a calculated quantity based on the

protein sequence. The extinction coefficient is a function of three specific amino acids
present in the protein structure, which are: tryptophan, tyrosine and cysteine. Their

respective extinction coefficients are 5000, 1490, and 190 M-1cm-1. The monomer units
present in the GFP fusions are 1 tryptophan, 9 tyrosine, and 2 cysteine, which equates to

38

19,160 M-1cm-1. The cuvettes used have a 1 cm solution path length so the laser can

permeate the solution.
2.7.3 Fluorescence
In these studies, fluorescence was used to quantify protein to get a sense of what

the yields were. High fluorescence intensity denoted high soluble protein yields. The

samples were loaded on a 384-well microplate and fluorescence was measured using a
Biotek Synergy H1 MultiMode Plate Reader (Figure 10). Fluorescence was determined
by using a monochromator with an excitation of 485 nm and an emission of 528 nm at

Gain 50. Immediately after cell lysis, 50 |iL aliquots of samples were pipetted on the

well, so that volume would remain uniform throughout. Subsequent dilutions, needed to
aid in the determination of linear fluorescence, were made in PBS (2.7 mM KCl, 10 mM

Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl). After dilutions were made, 50 u aliquots
were pipetted into empty wells on a solid microplate (Table VII).

Figure 10 Synergy H1 Microplate Reader used for Fluorescence Spectroscopy.
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Table VII Dilutions to calculate fluorescence.
Time (hours)
Sample (gL)
0-10
1
2
3
1
11-24
1
1

PBS (gL)
49
48
47
199
99
49

Pipette (uL)
50
50
50
50
50
50

2.7.4 SDS-Page

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was
used to confirm the molecular weight of the proteins expressed and purified. After
completion of purification, each purification step and a sample collected prior to

sonication was used as a control. An unopened Bolt 4-12% Bis-Tris Plus cassette was
loaded into a gel tank container filled with MES SDS buffer. The first lane on a gel is
loaded with 5 uL SeeBlue Pre-Stained Protein Standard (Life Technologies), a molecular
weight ladder, the lanes after were loaded with samples collected during the protein
purification steps and a single expression point for comparison. All samples following the
marker had a total volume of 20 uL, which consisted of 5 uL LDS Sample Buffer (4X), 2

u Reducing Agent (10X), x u sample and the remainder with RO water.
Electrophoresis was conducted at 200 volts for 22 minutes, stopping when the dye

reached the base of the gel. The gel was then carefully removed from the cassette and
washed with water to slip off without being torn. The resulting gel was suspended in 100

mL of fixing solution (50:40:10 / methanol: acetic acid: H2O) for an hour. Then the gel

was suspended in 100 mL Coomassie staining solution (1-gram Coomassie R250, 100
mL glacial acetic acid, 400 mL methanol, and 500 mL H2O) for 2 hours. Afterwards the
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gel was suspended in 100 mL de-stain solution (70:20:10 / H2O: methanol: glacial acetic
acid) overnight, to allow enough time for the bands to become visible.
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CHAPTER III

RESULTS AND DISCUSSION

3.1 Ara Expression
In order to understand the ara expression system, it will be treated like a classical

induction, where the inducer is added at a certain OD600. At OD600 = .8, the system was

induced with 0.05% L-arabinose, eventually increased to 0.2%. Since the ara system is
more tightly regulated than the lac system, induction is necessary to initiate transcription.
In hourly increments, before and after induction, 1.2 mL samples were collected for

OD600 measurements and for small scale cell harvesting. The samples are then lysed to
test for fluorescence intensity, which acts as a biological marker for protein expression.
The lysed samples collected hourly were analyzed for fluorescence which depicts the

behavior of the protein expression system. Once a series of plots are generated to
understand the behavior of the ara system, one can determine the optimal expression time

point to harvest the cells for maximum protein yields. The ara system was evaluated at
two different inducer concentrations and was also evaluated with ampicillin and

kanamycin as the resistant genes to see which expressed optimally.
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3.1.1 Growth
Unless otherwise noted, all experiments in the ara system were conducted in
Terrific Broth Auto-Induction media recipe from Formedium, but with the inducer

switched to arabinose. Depending on the selective marker of the culture, ampicillin or
kanamycin were used as the selective agents. A careful experiment with the ara vector,
p5A2 (Figure 7) was conducted. As shown on the plots, all pre-induction measurements

were placed on the negative x-axis, while the origin corresponds to the time when target
protein was induced with arabinose. Everything on the positive x-axis relates to the post

induction behavior. Figures 11 and 12 show that before arabinose is added into the media,
the energy in the system is used for cell growth. Once the inducer is added, the energy

used for cell growth is redirected towards protein production, however, in the ara system,

further cell growth is not immediately precluded. Figure 12 shows after arabinose is
added, the OD600 rises until 5 hours post-induction then it starts to decline, at which point

the cells are probably lysing. After 10 hours post-induction the OD600 rises again while
the fluorescence continues to decline after 4 hours post-induction (Figure 14). A possible

explanation for the increase in OD600 is cells that lost their plasmids are starting to
increase in population while the cells that retain their plasmids are lysing. Cells that lose

their plasmids compete for resources but will not make any protein (Figures 11 and 12).
To avoid overgrowth of cells that lost their plasmids, it is highly recommended to stop

the fermentation at the optimal time of 4 hours post-induction.
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Figure 11 Raw OD600 for a GFP fusion protein in the ara system.
A typical growth curve for a GFP-37R fusion-protein with the araC regulator and the ampicillin
resistance marker (p5A2) induced with 0.05% L-arabinose stock solution. Fermentation
conditions were conducted at 235 RPM, 37°C with a batch volume of 125 mL.

In the lag phase, when the starter cultures are inoculated into the media, the cells

need time to adjust to their new environment so the growth will be relatively slow.
Numerically, the optical density, which is the amount of light that penetrates the sample

is proportional to the number of cells present in the population, stops being linear around
OD600 ~ 0.45; linear values were calculated from dilutions (Table VI) to generate a new
plot (Figure 12). Throughout the fermentation, the pH was checked after samples were

collected and centrifuged, to avoid contamination of the pH probe (Figure 13) to
determine if pH changes had any effect on protein expression. It can be concluded that

the pH stayed constant throughout the experiment which means the salt buffers in the

media worked.
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Figure 12 Corrected OD600 for GFP-37R from p5A2.
After OD600 = .45, the OD600 vs concentration curve becomes nonlinear so dilutions are made to
calculate the cell count. Cell culture and fermentation conditions are the same used for Figure 11.
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Figure 13 pH of a GFP-37R from p5A2.
The culture and fermentation conditions are the same as Figure 11. The pH was measured to see
how acidic the media becomes and the impact on protein expression in the ara system.
Throughout the fermentation, the pH of the media stayed relatively constant.
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3.1.2 Fluorescence
GFP in these studies were used as a reporter for protein expression. Fluorescence

was used to quantify soluble protein concentration in these experiments. For the ara
system, in the absence of arabinose, AraC binds tightly to the half sites araI1 and araO2

in a process called DNA looping, which sterically hinders the RNA polymerase and
prevents access to the PBAD promoter, which blocks transcription and prevents the
formation of fluorescent protein being visually observed from the cells or growth media,
since the ara system is more restrictive than the lac system. Once the OD600 reached 0.8,
the system was induced with 0.05% (0.5g/L) arabinose stock solution which resulted in
greening of the media and harvested 1.2 mL hourly samples becoming visibly green,

which indicates that protein production is occurring. Pre-induced pellets exhibit a whitegrayish color. Figure 14 shows that from t = 0 to t = 4, the fluorescence intensity
increases as a function of time. Compared to the lac system, the protein is manufactured

at a higher rate, but also consumes energy sources at a higher rate. Overproduction of
protein is common in bacterial expression systems that produce protein at a high rate,

which can lead to misfolded proteins, thus called inclusion bodies, which can be detected
in the protein purification steps by SDS gel electrophoresis. [15] As the growth media
and harvested cells turn green, an indicator of protein expression, it allows for

fluorescence characterization during the cell lysis stages. After 4 hours post-induction,
the fluorescence starts to decrease which indicates the protein is either going into

inclusion bodies or protein degradation is involved. From Figure 14, the fluorescence
reaches a maximum value at t = 4, which denotes the optimal time for protein expression

in the ara system and cell harvesting should proceed immediately. Continued protein
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synthesis will lead to less soluble protein yield. After 4 hours, the surplus protein is either
going into inclusion bodies due to overproduction or protein degradation is occurring.
Misfolded proteins can be recovered by solubilizing in guanidine or urea buffer solutions.

[15]
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Figure 14 Fluorescence intensity of a GFP-37R culture in the ara system.
The RFU (relative fluorescence unit) is the amount of fluorescence from the disrupted cells at
certain time points during the fermentation. The culture conditions are the same as Figure 11. The
decrease in fluorescence after 4 hours post-induction can be attributed to protein degradation or a
surplus of protein going into inclusion bodies as a result of overproduction.
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Figure 15 The amount of protein per cell as a function of time.
The RFU/cell describes the behavior of the protein as a function of time. RFU (relative
fluorescence unit) denotes the amount of GFP-37R manufactured in the cell as a function of time.
The culture and fermentation conditions are the same as Figure 11. After 4 hours post induction,
the cells are making less protein due to limited energy resources in the media and the possibility
that some of the cells that lost their plasmids are starting to populate in the media.

To test for inclusion bodies, the insoluble fractions of the lysed cells were treated

with refolding buffer solutions to recover any misfolded proteins, however, after 3 days

of sitting in guanidine and urea solutions, no visible green solution was observed which
indicates there was no protein recovered. Generally, if there was overproduction of
protein, the AraC protein in the cells would be in the form of insoluble inclusion bodies.

[15] However, looking at a Bolt 4-12% Bis-Tris Plus gel (Figure 16) the AraC cells with

a molecular weight of 38 kDa appear in the soluble fraction, which indicates there were
no inclusion bodies present. The decrease in fluorescence, also confirmed by the gel with
decreasing blob sizes as a function of time, is attributed to protein degradation. The
insoluble bands that appear on the GFP-37R bands represent the degraded protein. From

the fluorescence data (Figure 14), it can be concluded that while the protein is generated

at a faster rate it must be consuming energy resources at a faster rate and after 4 hours
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post-induction, there is very few resources for the cells to sustain a high protein
production rate.

Figure 16 SDS PAGE of a GFP-37R in the ara system.
SDS PAGE of fermentation time points with both soluble and insoluble extracts for the GFP-37R
expression. The molecular weight of GFP-37R is 43 kDA and the AraC protein is 38 kDA. The
SDS Page was to confirm the validity of the fluorescence data and to see what is happening to the
protein. The AraC protein would show up in the insoluble extracts if there was an overproduction
of protein going into inclusion bodies.

The experiment was conducted again for consistency and yet again the

fluorescence confirmed that after 4 hours, protein degradation occurs (Figure 17). After 4
hours, due to the increasing band sizes of the AraC protein, it is possible the system needs

more energy to sustain itself. Overall, this system is inefficient after 4 hours post
induction.
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Figure 17 Fluorescence Intensity plot of a secondary GFP-37R expression.
RFU measurements were conducted on a secondary GFP-37R expression to verify that protein
degradation occurred after 4 hours post-induction.
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Figure 18 SDS PAGE of a secondary GFP-37R expression.
SDS PAGE of the soluble extracts from a GFP-37R expression from a p5A2 culture to verify
protein degradation after 4 hours post-induction.

3.1.3 Arabinose concentration
To address the energy shortfall, another careful experiment was conducted this

time comparing the arabinose concentration at 0.05% and at 0.2% (Figure 19). At higher
arabinose concentration, the optimal expression point increases to 6 hours post-induction
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(t=6) whereas at 0.05% arabinose concentration is situated at t = 4. While the system still

undergoes protein degradation after 6 hours, the fluorescence is greater overall than when
induced with 0.05% arabinose solution. Possible explanations for the protein degradation
may include the limited availability of energy sources after 6 hours of fermentation, and

older cells lysing and releasing their enzymes in the growth media.

• 0.05% arabinose
■ 0.2% arabinose

Figure 19 Fluorescence intensity GFP-37R at different induction levels.
Fluorescence intensity (RFU) was measured to compare protein expression levels at different Larabinose concentration, 0.05% (blue) and 0.2% (orange). Culture conditions were conducted at
235 RPM, 37°C with a batch volume of 125 mL. The culture selected was from p5A2.

3.1.4 Antibiotic

Another parameter tested in the ara system was the choice for antibiotics. In this
section we evaluate the antibiotics of ampicillin and kanamycin to see if the ara system
expresses protein more optimal in one antibiotic resistance or if levels of expression

between the two are similar enough while maintaining the arabinose concentration at

0.2%. The frozen stocks labeled p5A2 and p5A4 (Figure 7), which contained the
antibiotic resistances for ampicillin and kanamycin respectively were expressed. An

experiment showed that ara expression with ampicillin was the better than the kanamycin

51

variant (Figure 20); however, due to high variability in the data this is not a statistically

significant difference. Consistent experiments have shown that p5A4 (ara-kan) is about
the same if not slightly better than p5A2 (ara-amp) (Figure 21), but again this difference

is too small to establish a significant difference. A possible explanation could be that

starter culture for ara-kan may had poor growth during overnight incubation. Another
possibility, during the fermentation, ara-amp was better aerated than ara-kan. An

additional possibility could be during the cell lysis, the ara-kan cells were slightly more
diluted than the ara-amp thus making the fluorescence intensity values lower for ara-kan
than with ara-amp.

300000

200000

• ara-amp
■ ara-kan

100000

0 ■

-5

0

5

10

15

20

25

time (hr)

Figure 20 Fluorescence levels of GFP-37R with different resistant markers.
Fluorescence levels (RFU) for GFP-37R protein from lysed cells. The cultures selected were from
p5A2 (ara-amp) and p5A4 (ara-kan) to determine if one had better expression levels. The
fermentation conditions were conducted at 235 RPM, 37°C with a batch volume of 125 mL.
Cultures were induced with 0.2% L-arabinose.
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Figure 21 GFP-37R expression with different antibiotic markers.
A GFP-37R expression between cultures p5A2 (orange) and p5A4 (blue) to test if ara-amp was
more optimal than ara-kan. Cultures were expressed in Terrific Broth autoinduction media and
induced with 0.2% arabinose. The results also confirm the best times to harvest the cells in an ara
expression remains at 6 hours post-induction.

The ara system with both antibiotic vectors exhibit protein degradation after 6

hours post-induction so harvesting the cells after 6 hours would be recommended.
3.1.5 Comparison to IPTG Induction

From strategic planning, it was decided that p5A4, ara-kan, was the optimal
choice for the ara expression; any future experiments on optimization of an ara

expression should include the kanamycin resistance. The fluorescence intensity is a
strong indicator of protein expression; however, protein purification can also substantiate
the results of the fluorescence data. As such, the ara system was compared to our

standard induction, IPTG, in our lab. To induce with IPTG, the appropriate frozen stock
or colony must contain the lacI repressor, so the frozen stock labeled “p5A5” was
selected to compare with an arabinose-inducible vector. The cultures p5A4 and p5A5 are
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essentially the same GFP fusion protein with the same antibiotic resistance, but with

different promoters. The expression conditions were conducted at 1 L batch volume,
37°C, orbital shaker at 200 RPM, and induction occurred at OD600 ~ 0.8. The p5A4 was

induced with 0.2% arabinose while p5A5 was induced with 1 mM IPTG. Figure 22
confirms that the ara system is optimal at 6 hours post-induction, while for an IPTG

induction, it is recommended to harvest the cells at 12 hours post-induction. However, for
p5A4, the cells were harvested at 7 hours, which is shown in Figure 22, where the data

collection stops after 7 hours. For p5A5, the cells were harvested at 20 hours. From

Figure 22, the expression levels were similar enough at the end of the fermentation cycles
for both cultures. Had the reactions been stopped at their optimal points, the fluorescence

levels are still similar enough. During the protein purification analysis, ara-kan had a

yield of 308 mg/L whereas the culture induced with IPTG had a yield of 292 mg/L.
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Figure 22 Fluorescence levels of GFP-37R with different inducers.
Fluorescence levels of GFP-37R comparing the inducers L-arabinose (blue) and IPTG (orange).
Cell cultures from p5A4 (ara-kan) and p5A5 (T7-kan) were selected to induce with 0.2% Larabinose and 1 mM IPTG respectively. Fermentation conditions were conducted at 37C, 200
RPM in 1 L batch volume. The fermentation for ara-kan was stopped at 7 hours post-induction
while for IPTG induction was stopped at 20 hours post-induction. Cells were immediately
harvested for protein purification.
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3.2 Lac Expression
The lac system is said to be leakier than the ara system. However, with the lac

operon, cell cultures from plasmids p5A3 and p5A5 are inducible with lactose, galactose
or IPTG. The idea of doing an autoinduction experiment with lactose or galactose as the

inducer is to run it until the optimal time to harvest the cells without monitoring the
OD600. Contrary to autoinduction practices, samples were collected for OD600

measurements and fluorescence intensity on an hourly basis. To optimize protein

expression of ELP-GFP fusion using lactose or galactose, a series of expressions were
run in parallel with the inducers added to the media at the start. The cell cultures were

also tested to see under which resistance marker did the expression had optimal levels of

fluorescence.

3.2.1 Autoinduction with Lactose
Autoinduction is the special case where the growth media contains two different

carbon-energy sources (glucose and lactose), and the inducible promoter is switched

automatically on once all the glucose is consumed. Unless otherwise noted, similar with
the arabinose inducible experiments, autoinduction with lactose were performed in the

same media and fermentation conditions. These set of experiments leveraged the lac

operons, but differ in the resistance markers. The culture p5A3 which will be denoted as
“T7-amp” and p5A5 which will be denoted as “T7-kan” were selected. It is worth noting

that the lac system is leakier than the ara system.
3.2.1.1 Growth

To minimize unintended induction of the overnight cultures from T7-amp and T7-

kan, cell cultures should never grow beyond 12 hours because at certain concentration,
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the cultures turn green, which indicates the cells are making protein on their own before

induction. Figures 23 and 24 are typical growth curves when using lactose as the inducer.
The lac and ara systems do not behave the same way. The ara system continues to grow,

followed by cell death, then at some point starts to grow again, whereas lac system once
the autoinduction process occurs, the growth steadily increases since the bulk of the

energy is redirected from cell growth to protein production.

• T7 amp
■ T7 kan

Figure 23 Raw OD600 data to the lac system of different resistant makers.
A typical Raw OD600 plot to compare T7 amp (blue) vs T7 kan (orange). The growth conditions
occurred at T = 37°C, 200 RPM in Terrific Broth AIM. The system was also well-aerated.
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T7 lac

• T7 amp
■ T7 kan

Figure 24 Calibrated growth curve of GFP-37R in the lac system.
From Figure 23, a calibrated growth curve to compare the T7 lac system between ampicillin
(blue) and kanamycin (orange). At OD600 = 0.45, the OD600 vs concentration curve becomes
nonlinear so a calibration curve was generated to calculate the cell count after OD600 = 0.45. The
fermentation conditions were conducted at 235 RPM, 37°C with a batch volume of 125 mL.
Cultures from p5A3 and p5A5 were selected to compare growth levels between T7-amp (blue)
and T7-kan (orange) respectively.

3.2.1.2 Induction time

It is common practice to have both carbon-energy sources present in the media
when doing an autoinduction with lactose; however, a closer look reveals this is not

optimal for protein expression. Figure 25 shows when the lactose is added at the
beginning with the other media components, the energy that would be used for cell
growth is directed towards protein production from the start, albeit at a very slow rate.

Since lactose is a strong inducer, it binds very tightly to the lacI repressor, which in turn,

causes unintended induction before the cultures approach saturation. Unintended
induction unblocks transcription of T7 RNA polymerase and initiates the process of
protein expression. In the long run, protein production is minimized. Another unintended

consequence is the growth will be very slow. In this case, it is best to induce with lactose
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the same way as with IPTG. For optimal expression levels, it is best to induce with

lactose at OD600 from 0.5-1. An OD600 of 0.8 is routinely used in our lab. Without the
lactose to bind to the lacI, the cells will utilize glucose as the primary energy source and

allow cells to grow to a higher cell density which becomes favorable when switching
metabolism to lactose.

Figure 25 RFU of GFP-37R to compare induction times.
Culture p5A5 was selected and grown at 235 RPM, 37°C with a batch volume of 125 mL but
induced at t = 0 (blue) and at OD600 = 0.8, to determine which had better protein expression
levels. Cultures were expressed in Terrific Broth autoinduction media and induced with 0.2%
lactose.

3.2.1.3 Antibiotics
Cultures p5A3 and p5A5, T7-amp and T7-kan respectively were again selected

however, this time the expressions were scaled up to 1 L batch volumes and the cultures
were induced with 0.2% lactose at OD600~0.8 to prevent early uptake and metabolism of
lactose. From Figure 26, its noted that T7 kan is more stable than T7 amp. A possible

explanation may be that with ampicillin as the selective agent, secreted P-lactamase can
possibly destroy the ampicillin in the media before saturation, thereby allowing cells
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without plasmids to grow and compete for resources. Cells without plasmids usually
remain a minor fraction relative to cells with plasmids. With kanamycin as the resistance

marker, the potential for overgrowth of cells that have lost plasmids is eliminated and
cells are able to grow to saturation without issues. The data presented in Figures 32 and
33 in Appendix A showed similar expression levels, however, allowing the overnight
cultures to incubate longer than 12 hours leads to longer lag times and possibility of

lower fluorescence levels. To minimize lag growth, a possible suggestion would be to let
the overnight cultures operate for less than 11 hours.
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Figure 26 The fluorescence levels of GFP-37R with different resistance markers.
Fluorescence Intensity (RFU) to compare protein expression levels of GFP-37R with ampicillin
(blue) and kanamycin (orange) as resistance markers. The fermentation conditions were
conducted at 200 RPM, 37°C with a batch volume of 1 L. Cultures from p5A3 and p5A5 were
selected for T7-amp and T7-kan respectively and induced with .2% lactose. For more data, look
at Figures 32 and 33 in Appendix A.

3.2.1.4 Protein Purification

After a few experiments doing 125 mL batch volumes with T7 amp and T7 kan,

the experiment was scaled up to 1 L batch volumes in order to compare concentration and
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protein yields. The fluorescence data between the different volumes were similar so
protein purification via inverse temperature cycling was conducted to measure how much
protein was made. Since T7 kan was sonicated first and centrifuged on cold settings to

remove cell debris, a visible green cross-section appeared on the insoluble fraction which

denoted that not all the cells were thoroughly disrupted. So when T7 amp was disrupted
next, two sonication cycles were applied, which resulted in a smaller green cross-section

of the insoluble fraction. Followed by protein loss during the thermocycling steps, T7
amp had a higher protein yield, which amounted to 508 mg/L whereas T7 kan had a
protein yield of 408 mg/L, which is consistent with the loss of protein during purification

since the fluorescence data indicated more protein in this expression. Prior to the hot
cycles, when the cell cultures are treated with 2M (NH4)2SO4 and heated at 60°C, the
protein flocculates but there is minimal phase separation The resulting hot spin only

removes some of the protein in solution, but a large amount still remains in solution, so a

subsequent cold spin is required to remove the remainder of the protein in solution and
turn it insoluble, then recombine with the insoluble fraction from the hot spin. Other areas

of protein loss occurred in subsequent cold cycles after resuspending the insoluble protein
in PBS solution. The resulting insoluble fraction from a cold spin, which is mostly waste,

had some fluorescent pellet adhering to the waste.
3.2.2 Autoinduction with Galactose

Identical to autoinduction with lactose, galactose replaces lactose as the inducer.
For autoinduction in BL21 (DE3), glucose once again prevents uptake of galactose. In
BL21 (DE3), the cell imports galactose from the growth medium when glucose is

depleted to concentrate galactose. Due to a lack of a galactokinase, galactose is unable to
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be metabolized by BL21 (DE3), which allows galactose to rapidly accumulate to

concentrations high enough to induce target protein about as rapidly and efficiently as
lactose does.
3.2.2.1 Growth

Since galactose is a weaker inducer than IPTG and lactose, it does not bind to lacI
as tightly as either, so galactose can be added to the media prior to inoculating with

starter cultures without causing unintended induction of cell cultures before approaching
saturation. Figure 27 shows both T7-amp and T7-kan having similar levels of growth.
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Figure 27 Growth Curve for an autoinduction with galactose.
Growth Curve for an autoinduction with galactose comparing ampicillin (blue) and kanamycin
(orange). The fermentation conditions were similar to those of an autoinduction with lactose.
Cultures from p5A3 and p5A5 were selected again. Cultures were expressed in Terrific Broth
autoinduction media and induced with 0.1% galactose.

3.2.2.2 Fluorescence

Similar to autoinduction with lactose, kanamycin as the selective marker has
better expression levels than ampicillin as the selective marker. Looking at the Figure 29,
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which describes the amount of protein as a function of time, after 6 hours of
fermentation, the glucose is depleted and the concentration of galactose is strong enough

to induce target protein, which essentially starts the autoinduction process. During the
pre-induction stages, the cells are growing and the galactose concentration is too weak to

induce target protein. The fluorescence during the pre-induction stages is minimal.
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Figure 28 Fluorescence intensity (RFU) plot an autoinduction with galactose.
Fluorescence intensity (RFU) of a protein expression of GFP-37R with galactose as the inducer
comparing the resistance markers of ampicillin (blue) and kanamycin (orange). The fermentation
conditions were the same as in Figure 27. For more data, look at Figures 34-36 in Appendix B.
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Figure 29 Protein behavior of an autoinduction with galactose.
Protein behavior (RFU/cell) plot of an autoinduction with galactose comparing between
ampicillin (blue) vs (kanamycin) as the antibiotic markers. At around t = 6, the system runs out of
glucose and the concentration of galactose is strong enough to induce GFP-37R.

3.2.2.3 Protein Purification
Like autoinduction with lactose, cultures p5A3 and p5A5 were also expressed in 1
L batch volumes and induced with galactose at the start of the fermentation. The

fluorescence data shows that p5A5 had better levels of expression, so the cells were
harvested for protein purification in order to have another method of quantifying. During

the protein purification steps, protein loss was common in the thermocycling steps

outlined in Table 4. However, after sonication, and running a cold cycle, both cultures
showed a green cross section of the insoluble fraction, which means the cells were not

thoroughly disrupted. However, the yields were 578 mg/L for T7 amp and 522 mg/L for

T7 kan. If all the cells would have been thoroughly disrupted, it is possible T7 kan would

have higher yields, consistent with the fluorescence data. The methods for protein
purification were altered and the scheme for Table 5 were followed. A separate

experiment with 2 microcentrifuge tubes each consisting 1 mL culture solution
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containing 2M (NH4)2SO4 were placed in opposite heat environments. One was placed in
the refrigerator whereas the other was placed in a convection oven at 60°C. The tube at
60°C showed partial phase separation whereas the tube placed in the refrigerator showed

near 100% phase separation. The tubes were then centrifuged at 15000 rcf at 60°C and
4°C, respectively. The tube that was cold spun had a large fluorescent insoluble pellet

with soluble waste. The tube from the hot spin had a small fluorescent pellet with
fluorescent solution, an indication that there was not 100% protein separation, so all but

once hot cycle was eliminated and replaced with cold temperature spins. The formerly
hot spins were still suspended in 2M salt but spun cold. The resulting change in strategy

resulted in minimal protein loss between the insoluble steps, however, when cold
spinning a solution without the 2M salt, minimal protein was noted adhering to the

wastes minimal fluorescence.

3.3 Vmax
The commercial strain for Vibrio natriegens is sold as Vmax by Synthetic

Genomics. For these experiments, transforming a plasmid into Vmax yielded very few
colonies. Attempts to transform p5A2 and p5A3 were unsuccessful. Only the GFP-based

p4E9 aka ”GFP-73” was successfully transformed into Vmax so it was used in these

experiments. Since Vmax has a fast growth rate and an optimal temperature at 37°C,
cultures were grown at 30°C for 12-16 hours to slow the growth and prevent overgrown
cultures being used for inoculation. BL21 overnight cultures were grown at 37°C.
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3.3.1 Growth
In these studies, Vmax was studied for its doubling rate compared to BL21 (DE3).

Since Vibrio natriegens is a halophilic marine bacterium, growth medium must be
supplemented with V2 salts or grown in Enhanced 2xYT medium. Vmax cultures grown

in LB-Miller without the extra salts resulted in slower growth rates than BL21 cultures
(unpublished data). Common growth rates for Vmax cultures ranged from 19-29 minutes
whereas for BL21 (DE3) ranged from 40-60 minutes. In Figure 30, BL21 (DE3) has a
doubling rate of 40 minutes whereas Vmax cultures grown in LB-Miller and Enhanced

2xYT, each supplemented with V2 salts, had doubling rates of 28 and 24 minutes,

respectively. Since Enhanced 2xYT media has more salt and is nutrient denser than LBMiller, the growth conditions for Vmax cultures are slightly favorable. Growth rates for

Vmax cultures grown in Enhanced 2xYT media supplemented with V2 salts have been as
fast as 18 minutes (data not shown).

• BL21
■ Vmax LBV2

▲ Vmax E2xYT+V2

Figure 30 Growth curve comparing protein expression of GFP-73 in different hosts.
The GFP-73 growth curve comparing BL21 in LB media (blue) with Vmax in LB-Miller + V2
salts (orange) and Enhanced 2xYT + V2 salts (grey). The fermentation conditions were
conducted at 200 RPM, 37°C with a batch volume of 400 mL for 6 hours post-induction. Cultures
from p4E9 in their BL21 (DE3) and Vmax frozen stocks were inoculated into their respective
growth media.
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3.3.2 Protein Expression
Since Vibrio natriegens has a fast growth rate and a high oxygen uptake rate,

demand must be satisfied so Vmax cultures were expressed in 20% flask volume, or 400
mL batch volumes using 2 L flasks in parallel with BL21 (DE3) to have a qualitative
comparison. Based on the data from previous araBAD expressions, it was decided the
GFP-73 cultures would be induced with 0.2% arabinose and expressed for 6 hours post

induction. Figure 31 shows that despite Vmax cultures having a faster growth rate than

BL21, Vmax does not appear to be optimal for protein expression based on fluorescence;
however, fluorescence may not be the best way to compare protein expression between
different bacterial hosts since the hosts may not behave the same way and one may auto
fluoresce, so a control would be needed. Fluorescence may be used to compare protein

expressions within the same host, to compare expression systems, antibiotic markers, and
growth medium, because the hosts behave the same way. In order to compare the two

organisms, protein purification by inverse temperature cycling was selected to provide an

extra layer for comparison and verify the validity of the fluorescence data.
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Figure 31 Fluorescence Intensity of GFP 73 in different hosts.
Fluorescence Intensity (RFU) plot comparing BL21 to Vmax and Vmax in LB-Miller
supplemented with V2 salts was compared to another Vmax culture expressed in Enhanced 2xYT
media supplemented with V2 salts. The fermentation conditions are the same in Figure 30.

Nonetheless, between the different growth media tested for Vmax, cultures grown

in LB-Miller supplemented with V2 salts had better protein expression than cultures
grown in Enhanced 2xYT media supplemented with V2 salts. A possible explanation is
that LB-Miller with the V2 salts had a starting pH of 7 and a final pH of 7.77, whereas,

cultures grown in Enhanced 2xYT with V2 salts, had a starting pH of 7.4 and had a pH of

6.28 at the end of the fermentation (data not shown). It can be reasoned that LB-Miller
with V2 salts metabolized amino acids and got more basic, while Enhanced 2xYT with

V2 salts metabolized glucose and got slightly more acidic. An underlying assumption is
that cultures getting more basic will have higher levels of protein expression, but more

data would be needed to verify this. Due to poor protein production by Vmax, the best

times to harvest the cells with Vmax as the host, in the ara system, is between 2 and 3
hours.
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3.3.3 Protein Purification

Since fluorescence was not enough to verify if BL21 (DE3) had better protein
expression than Vmax, all three cultures were harvested for protein purification. The
protein yields for BL21 (DE3), LB-Miller + V2 salts, and Enhanced 2xYT + V2 salts

were 289 mg/L, 143 mg/L and 52 mg/L respectively. These results confirm the validity of

the fluorescence data in Figure 31. The solution from the BL21 derived culture was

noticeably greener than the Vmax derived solutions which is a visual indicator that BL21
produced more protein than Vmax.

3.4 Future Considerations
In future work, it would be ideal for autoinduction media to be supplemented with

trace metals to further saturate cell growth, and further optimize protein expression for
cultures in BL21 (DE3).

For Vibrio natriegens, its evident that Vmax is not optimized for protein
expression so a different strain would be recommended. The strains, WT Vibrio

natriegens DSM 759, ATCC 14048, or NCMB 857, available in Germany, would be
recommended. Also, bacterial transformation via electroporation would be highly

recommended since Vibrio natriegens has very low transformation efficiency when

transformed by chemically competent cells. Since Vibrio can grow rapidly in a wide

range of carbon-energy sources, it would be best to start with sucrose. Another
recommendation would be to express Vibrio cultures in baffled flasks, which allow better

aeration.
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Another consideration would be to use a chromatography technique for protein
purification, in particular, high performance liquid chromatography (HPLC) or
hydrophobic interaction chromatography (HIC) selectively for GFP fusion proteins.
Chromatography techniques are commonly employed in industry for downstream
purification and would be ideal for this application.
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CHAPTER IV

CONCLUSION

In these experiments, the aim was to discover the optimal conditions for the

bacterial hosts, E. coli and Vibrio natriegens, and the expression systems, lac and ara in

order to optimize protein production of an ELP-GFP fusion. ELP constructs without the
GFP tag when expressed in standard LB media in BL21 (DE3) and induced with IPTG
produced anywhere between 100 and 200 mg/L of culture.[74] However, when the media

is switched to Terrific Broth Autoinduction Media (TB AIM) which is nutrient dense,
contains glucose and buffer components to allow faster cell growth and robust protein
production in BL21 (DE3) with variable promoters and resistance markers, the yields

were higher. In the ara system in BL21 (DE3), the yields were between 250 and 350

mg/L of culture. In the lac system, with lactose as the inducer, the yields were between
400 and 500 mg/L of culture. Also, in the lac system with galactose as the inducer, the
yields were between 500 and 600 mg/L of culture. When switching to Vmax, the yields

were lower but were evaluated in multiple media in the ara system. Also, due to Vibrio

natriegens having a fast growth rate and a very high O2 uptake rate, the batch volumes
for Vmax expression were lowered to 20% flask volume to satisfy demand. A Vmax
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culture grown in LB-Miller supplemented with V2 salts had yields between 100 and 200

mg/L of culture whereas a Vmax culture in Enhanced 2xYT media supplemented with
V2 salts had yields between 50 and 100 mg/L. Since V. natriegens has a natural
resistance to kanamycin, bacterial transformations with plasmids containing the
kanamycin resistance marker were not attempted.[66] Attempts to transform an ELPGFP fusion with 37 (GVGVP) repeats were unsuccessful so Vmax was only evaluated

with the 73 (GVGVP) repeats in the ara system and compared with BL21 (DE3).

While the ara system produces protein at a higher rate than the lac system, it
consumes energy resources at a higher rate and after 6 hours post-induction, the protein
begins to degrade leading to less soluble protein. An ara expression is more suitable for

short durations while an autoinduction with lactose or galactose are more suitable for

longer fermentation cycles. The ara system is more tightly controlled because it is

regulated via DNA looping by AraC. The lac system makes protein at a slower rate but is
more stable in the long run. In the autoinduction expressions, the protein yields and

fluorescence revealed that galactose yielded more protein than lactose as the inducer.
However, it should be noted the fluorescence data is more reliable than the yields from
protein purification. In the case of the resistant markers, even though the fluorescence

data revealed that kanamycin had better levels of protein expression than ampicillin, the

purified yields said the opposite. In the protein purification cycles, protein losses that
occurred during the hot cycles were common. A possible explanation may be that due to
the large amount of protein in solution, not all of it becomes insoluble when heated.
However, GFP when cooled, has shown to become insoluble when treated with

ammonium sulfate, thus leading to a change in protein purification protocol for GFP
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fusion proteins. Another factor that might have contributed to slightly lower fluorescence
intensity for lactose was the possibility the lysed cells for lactose were slightly more

diluted than the samples for galactose. Lactose prematurely binding to lacI prevents the

cells from growing to saturation and allowing metabolism to artificially switch to lactose
once glucose is depleted. Galactose as the inducer does not bind as tightly to the lacI and
because of the lack of galactokinase activity, cannot be metabolized. Being unable to
metabolize this sugar, the concentration of galactose increases until it can effectively

induce target protein. This mechanism allows the cells to grow to saturation and once the
glucose is depleted, the transport proteins import the galactose and induce target protein.

Overall, if lactose did not bind tightly to lacI and allowed the cells to reach saturation
similar to galactose, fluorescence levels would probably be similar in both scenarios. The

best times to harvest the cells for an autoinduction with lactose are between 19 and 20

hours post-induction and 23 to 24 hours post-induction with galactose as the inducer.
Using a more optimized strain for Vibrio natriegens may enable it to replace E.

coli in the labs. However, Vmax, the strain currently used in our lab is not optimized for
protein expression, based on studies from the plasmid, p4E9, an arabinose inducible GFP

fusion protein, which was the only successful transformation into Vmax. Vmax may have

a poor ability to redirect the energy from cellular growth to protein production because
the arabinose plays a dual role for induction and as a carbon-energy source for V.

natriegens. Transforming a GFP-tagged protein with an IPTG inducible vector may be

more stable since IPTG, similar to BL21 (DE3) is not consumed or metabolized in the

media by the host.
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Appendix A

Autoinduction with Lactose

• T7-amp
■ T7-kan

Figure 32 Autoinduction with Lactose.
The fluorescence intensity (RFU) of an autoinduction with lactose to compare protein expression
levels of GFP-37R with ampicillin (blue) and kanamycin (orange) as resistance markers. The
fermentation conditions were conducted at 200 RPM, 37°C with a batch volume of 1 L. Cultures
from p5A3 and p5A5 were selected for T7-amp and T7-kan respectively. The fermentation ran
for nearly 45 hours post-induction to determine the optimal time to harvest the cells.
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Figure 33 Autoinduction with Lactose.
The fluorescence intensity (RFU) of a GFP-37R with ampicillin (blue) and kanamycin (orange)
as resistance markers. The fermentation conditions were conducted at 200 RPM, 37°C with a
batch volume of 1 L. Cultures from p5A3 and p5A5 were selected for T7-amp and T7-kan
respectively. The proteins were expressed in Terrific Broth Autoinduction Media and induced
with 0.2% lactose at OD600 = 0.8. The expression operated for nearly 36 hours post-induction to
verify the optimal times for cell harvesting.
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Appendix B

Autoinduction with Galactose
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Figure 34 Autoinduction with Galactose
The fluorescence intensity (RFU) of a GFP-37R protein expression with ampicillin (blue) and
kanamycin (orange) as resistance markers. The fermentation conditions were conducted at 200
RPM, 37°C with a batch volume of 1 L. Cultures from p5A3 and p5A5 were selected for T7-amp
and T7-kan respectively. The proteins were expressed in Terrific Broth Autoinduction media and
induced with 0.1% galactose from the start of the fermentation.
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Figure 35 Autoinduction with Galactose.
The fluorescence intensity (RFU) of a GFP-37R protein expression with ampicillin (blue) and
kanamycin (orange) as resistance markers. The fermentation conditions were conducted at 200
RPM, 37°C with a batch volume of 1 L. Cultures from p5A3 and p5A5 were selected for T7-amp
and T7-kan respectively. The proteins were expressed in Terrific Broth Autoinduction media and
induced with 0.1% galactose from the start of the fermentation.
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Figure 36 Autoinduction with Galactose
The fluorescence intensity (RFU) of a GFP-37R protein expression with ampicillin (blue) and
kanamycin (orange) as resistance markers. The fermentation conditions were conducted at 200
RPM, 37°C with a batch volume of 1 L. Cultures from p5A3 and p5A5 were selected for T7-amp
and T7-kan respectively. The proteins were expressed in Terrific Broth Autoinduction media and
induced with 0.1% galactose from the start of the fermentation and operated for a total time of
nearly 44 hours to determine the optimal time to harvest the cells.
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otherwise for the purposes of notifying User of such changes or additions; provided that any such changes
or additions shall not apply to permissions already secured and paid for.

8.2.

Use of User-related information collected through the Service is governed by CCC's privacy policy,
available online here:https://marketplace.copyright.com/rs-ui-web/mp/privacy-policy

8.3.

The licensing transaction described in the Order Confirmation is personal to User. Therefore, User may
not assign or transfer to any other person (whether a natural person or an organization of any kind) the
license created by the Order Confirmation and these terms and conditions or any rights granted
hereunder; provided, however, that User may assign such license in its entirety on written notice to CCC in
the event of a transfer of all or substantially all of User's rights in the new material which includes the
Work(s) licensed under this Service.

8.4.

No amendment or waiver of any terms is binding unless set forth in writing and signed by the parties. The
Rightsholder and CCC hereby object to any terms contained in any writing prepared by the User or its
principals, employees, agents or affiliates and purporting to govern or otherwise relate to the licensing
transaction described in the Order Confirmation, which terms are in any way inconsistent with any terms
set forth in the Order Confirmation and/or in these terms and conditions or CCC's standard operating
procedures, whether such writing is prepared priorto, simultaneously with or subsequent to the Order
Confirmation, and whether such writing appears on a copy of the Order Confirmation or in a separate
instrument.

8.5.

The licensing transaction described in the Order Confirmation document shall be governed by and
construed under the law of the State of New York, USA, without regard to the principles thereof of conflicts
of law. Any case, controversy, suit, action, or proceeding arising out of, in connection with, or related to
such licensing transaction shall be brought, at CCC's sole discretion, in any federal or state court located in
the County of New York, State of New York, USA, or in any federal or state court whose geographical
jurisdiction covers the location of the Rightsholder set forth in the Order Confirmation. The parties
expressly submit to the personal jurisdiction and venue of each such federal or state court.lf you have any
comments or questions about the Service or Copyright Clearance Center, please contact us at 978-750
8400 or send an e-mail to support@copyright.com.

v 1.1
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Rights and Permissions (ELS) <Permissions@elseviercom>
Reply-To 'Rights and Permissions (ELS)* <Permissions@elsevier com>
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Mon. Dec7.2020 at753 PM

ELSEVIER
Dear Mr Blas Quiroga
We hereby grant you permission to reprint the material below at no charge in your thesis subject to the following
conditions:

1.
If any part of the material to be used (for example, figures) has appeared in our publication with
credit or acknowledgement to another soiree, permission must also be sought from that soiree, if surh
permission is not obtained then that material may not be indudedin your publication/copies.
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Suitable acknowledgment to the soiree must be made, either as a footnote or in a reference list at
the end of yoir publication, as follows:
“This artide was published in Publication title, W)l number, Author(s), Title of artide. Page Nos, Copyright
Elsevier (or appropriate Society name) (Year).*
3.

Vbir thesis may be submitted to your institution in either print or electroni c form.

4.

Reproduce on of this material Is confined to the pirpose for which permission is hereby given

5.
This permission is granted for non-excluslve world English tights only. For other languages please reapply
separately for each one required. Permission exdudes use in an electronic form other than submission. Should you
have a specific electronic project in mind please reapply for permission.
6.

As long as the artid e is embedded in your thesis, you ca n post/ share your thesis In the University repository

7.

Should your thesis be published commerdally, please reapply for permission.
8.
Posting of the full artide/ diapter online is not perm<tted. You may post an abstract with a link to the
Elsevierwebsitewww.elsevler.com, or to the article on SdenceOirect if it Is available on that platform.
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From: Administrator
Date: Sunday, December 06, 2020 03:57 AM GMT
Dear Blas Quiroga,
Thank you for contacting the Permissions Granting Team.

We acknowledge the receipt of your request and we aim to respond within seven business days. Your unique
reference number is 201206-001164.
Please avoid changing the subject line of this email when replying to avoid delay with your query.
Regards,
Permission Granting Team

From: Blas Quiroga
Date: Sunday, December 06, 2020 03:57 AM GMT
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This Agreement between Mr Blas Quiroga III ("YouT and Elsevier CEHevrer") consists of your license details and the terms and
conditions provided by Elsevier and Copyright Clearance Center
4972181454753
License Number
Dec 18,2020
License date
Licensed Content Publsher Elsevier
Trends in Genetcs
Licensed Content
Publcaron
Regulation of the l-arabmose opcron of Escherichia coli
Licensed Content Tide
Licensed Content Author Robert Schied
Dec1,2000
Licensed Content Date
Licensed Content Volume 1«
12
Licensed Content Issue
Licensed Content Pages 7
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Typed Use
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Number d
5
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Format
Are you the author of this No
Elsevier artcle’’
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Mr
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Portons
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Total
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1 The publisher for this copyrighted material is Elser er By clicking accept'm connection wth comptetng this Icensmg transaction
you agree that the Mowing terms and conditions apply to this transaction (along with the Bring and Payment terms and conditions
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GENERAL TERMS
2 Elsevier hereby grants you permission to reproduce the aforementioned material sublet to the terms and conditions indicated
https .OS 100 ccpyrçht comAAyAcccuntAvetMstkVleeprntsblefccenvelrcmnTyorders |sp7retocdb7e1052f03"4e 1c-0529-e0cÄde207öS4ÄemnJi

94

IM

12/25/2020

RightsLink - Your Account

3, Acknowledgement: If any part of the material to be used (for example, figures) has appeared in our publication with credit or
acknowledgement to another source, permission must also be sought from that source. If such permission is not obtained then that
material may not be included in your publication/copies. Suitable acknowledgement to the source must be made, either as a footnote
or in a reference list at the end of your publication, as follows:
"Reprinted from Publication title, Vol /edition number, Author(s), Title of article I title of chapter, Pages No., Copyright (Year), with
permission from Elsevier [OR APPLICABLE SOCIETY COPYRIGHT OWNER]." Also Lancet special credit - "Reprinted from The
Lancet, Vol. number, Author(s), Title of article, Pages No., Copyright (Year), with permission from Elsevier."
4. Reproduction of this material is confined to the purpose and/or media for which permission is hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be altered/adapted minimally to serve your work.
Any other abbreviations, additions, deletions and/or any other alterations shall be made only with prior written authorization of
Elsevier Ltd. (Please contact Elsevier’s permissions helpdesk here). No modifications can be made to any Lancet figures/tables and
they must be reproduced in full.
6. If the permission fee for the requested use of our material is waived in this instance, please be advised that your future requests
for Elsevier materials may attract a fee.
7. Reservation of Rights: Publisher reserves all rights not specifically granted in the combination of (i) the license details provided by
you and accepted in the course of this licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms
and conditions.
8. License Contingent Upon Payment: While you may exercise the rights licensed immediately upon issuance of the license at the
end of the licensing process for the transaction, provided that you have disclosed complete and accurate details of your proposed
use, no license is finally effective unless and until full payment is received from you (either by publisher or by CCC) as provided in
CCC's Billing and Payment terms and conditions. If full payment is not received on a timely basis, then any license preliminarily
granted shall be deemed automatically revoked and shall be void as if never granted. Further, in the event that you breach any of
these terms and conditions or any of CCC's Billing and Payment terms and conditions, the license is automatically revoked and shall
be void as if never granted. Use of materials as described in a revoked license, as well as any use of the materials beyond the
scope of an unrevoked license, may constitute copyright infringement and publisher reserves the right to take any and all action to
protect its copyright in the materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their respective officers, directors,
employees and agents, from and against any and all claims arising out of your use of the licensed material other than as specifically
authorized pursuant to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed, assigned, or transferred by you to any other
person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing signed by both parties (or, in the case of
publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any purchase order, acknowledgment, check
endorsement or other writing prepared by you, which terms are inconsistent with these terms and conditions or CCC's Billing and
Payment terms and conditions. These terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and publisher (and CCC) concerning this licensing
transaction. In the event of any conflict between your obligations established by these terms and conditions and those established
by CCC's Billing and Payment terms and conditions, these terms and conditions shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described in this License at their sole discretion,
for any reason or no reason, with a full refund payable to you. Notice of such denial will be made using the contact information
provided by you. Failure to receive such notice will not alter or invalidate the denial. In no event will Elsevier or Copyright Clearance
Center be responsible or liable for any costs, expenses or damage incurred by you as a result of a denial of your permission request,
other than a refund of the amount(s) paid by you to Elsevier and/or Copyright Clearance Center for denied permissions.
LIMITED LICENSE
The following terms and conditions apply only to specific license types:
15. Translation This permission is granted for non-exclusive world English rights only unless your license was granted for
translation rights. If you licensed translation rights you may only translate this content into the languages you requested. A
professional translator must perform all translations and reproduce the content word for word preserving the integrity of the article.
16 Posting licensed content on any Website: The following terms and conditions apply as follows: Licensing material from an
Elsevier journal: All content posted to the web site must maintain the copyright information line on the bottom of each image; A
hyper-text must be included to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/iournal/xxxxx or the Elsevier homepage for books at http://www.elsevier.com; Central Storage:
This license does not include permission for a scanned version of the material to be stored in a central repository such as that
provided by Heron/XanEdu.
Licensing material from an Elsevier book: A hyper-text link must be included to the Elsevier homepage at http://www.elsevier.com .
All content posted to the web site must maintain the copyright information line on the bottom of each image.
Posting licensed content on Electronic reserve: In addition to the above the following clauses are applicable: The web site must
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be password-protected and made available only to bona fide students registered on a relevant course. This permission is granted for
1 year only. You may obtain a new license for future website posting.
17. For journal authors: the following clauses are applicable in addition to the above:
Preprints:
A preprint is an author's own write-up of research results and analysis, it has not been peer-reviewed, nor has it had any other value
added to it by a publisher (such as formatting, copyright, technical enhancement etc.).
Authors can share their preprints anywhere at any time. Preprints should not be added to or enhanced in any way in order to appear
more like, or to substitute for, the final versions of articles however authors can update their preprints on arXiv or RePEc with their
Accepted Author Manuscript (see below).
If accepted for publication, we encourage authors to link from the preprint to their formal publication via its DOI. Millions of
researchers have access to the formal publications on ScienceDirect, and so links will help users to find, access, cite and use the
best available version. Please note that Cell Press, The Lancet and some society-owned have different preprint policies. Information
on these policies is available on the journal homepage.
Accepted Author Manuscripts: An accepted author manuscript is the manuscript of an article that has been accepted for
publication and which typically includes author-incorporated changes suggested during submission, peer reviewand editor-author
communications.
Authors can share their accepted author manuscript
• immediately
o via their non-commercial person homepage or blog
o by updating a preprint in arXiv or RePEc with the accepted manuscript
o via their research institute or institutional repository for internal institutional uses or as part of an invitation-only
research collaboration work-group
o directly by providing copies to their students or to research collaborators for their personal use
o for private scholarly sharing as part of an invitation-only work group on commercial sites with which Elsevier has an
agreement
• After the embargo period
o via non-commercial hosting platforms such as their institutional repository
o via commercial sites with which Elsevier has an agreement

In all cases accepted manuscripts should:
• link to the formal publication via its DOI
• bear a CC-BY-NC-ND license - this is easy to do
• if aggregated with other manuscripts, for example in a repository or other site, be shared in alignment with our hosting policy
not be added to or enhanced in any way to appear more like, or to substitute for, the published journal article.

Published journal article (JPA): A published journal article (PJA) is the definitive final record of published research that appears or
will appear in the journal and embodies all value-adding publishing activities including peer review co-ordination, copy-editing,
formatting, (if relevant) pagination and online enrichment.
Policies for sharing publishing journal articles differ for subscription and gold open access articles:
Subscription Articles: If you are an author, please share a link to your article rather than the full-text. Millions of researchers have
access to the formal publications on ScienceDirect, and so links will help your users to find, access, cite, and use the best available
version.
Theses and dissertations which contain embedded PJAs as part of the formal submission can be posted publicly by the awarding
institution with DOI links back to the formal publications on ScienceDirect
If you are affiliated with a library that subscribes to ScienceDirect you have additional private sharing rights for others' research
accessed under that agreement. This includes use for classroom teaching and internal training at the institution (including use in
course packs and courseware programs), and inclusion of the article for grant funding purposes.
Gold Open Access Articles: May be shared according to the author-selected end-user license and should contain a CrossMark
Jggfi, the end user license, and a DOI link to the formal publication on ScienceDirect.
Please refer to Elsevier's posting policy for further information.
18. For book authors the following clauses are applicable in addition to the above: Authors are permitted to place a brief summary
of their work online only. You are not allowed to download and post the published electronic version of your chapter, nor may you
scan the printed edition to create an electronic version. Posting to a repository: Authors are permitted to post a summary of their
chapter only in their institution's repository.
19 Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be submitted to your institution in either
print or electronic form. Should your thesis be published commercially, please reapply for permission. These requirements include
permission for the Library and Archives of Canada to supply single copies, on demand, of the complete thesis and include
permission for Proquest/UMI to supply single copies, on demand, of the complete thesis. Should your thesis be published
commercially, please reapply for permission. Theses and dissertations which contain embedded PJAs as part of the formal
submission can be posted publicly by the awarding institution with DOI links back to the formal publications on ScienceDirect.
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You can publish open access with Elsevier in hundreds of open access journals or in nearly 2000 established subscription journals
that support open access publishing. Permitted third party re-use of these open access articles is defined by the author's choice of
Creative Commons user license See our open access license policy for more information.
Terms & Conditions applicable to all Open Access articles published with Elsevier:
Any reuse of the article must not represent the author as endorsing the adaptation of the article nor should the article be modified in
such a way as to damage the author's honour or reputation. If any changes have been made, such changes must be clearly
indicated.
The author(s) must be appropriately credited and we ask that you include the end user license and a DOI link to the formal
publication on ScienceDirect.
If any part of the material to be used (for example, figures) has appeared in our publication with credit or acknowledgement to
another source it is the responsibility of the user to ensure their reuse complies with the terms and conditions determined by the
rights holder.
Additional Terms & Conditions applicable to each Creative Commons user license:
CC BY: The CC-BY license allows users to copy, to create extracts, abstracts and new works from the Article, to alter and revise the
Article and to make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the
user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if
changes were made and the licensor is not represented as endorsing the use made of the work. The full details of the license are
available at http://creativecommons.Org/licenses/bY/4.0.
CC BY NC SA: The CC BY-NC-SA license allows users to copy, to create extracts, abstracts and new works from the Article, to alter
and revise the Article, provided this is not done for commercial purposes, and that the user gives appropriate credit (with a link to the
formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not
represented as endorsing the use made of the work. Further, any new works must be made available on the same conditions. The
full details of the license are available at httpV/creativecommons orq/licenses/by-nc-saM.0.
CC BY NC ND: The CC BY-NC-ND license allows users to copy and distribute the Article, provided this is not done for commercial
purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives
appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor
is not represented as endorsing the use made of the work. The full details of the license are available at
http://creativecommons.Org/licenses/bY-nc-nd/4.0. Any commercial reuse of Open Access articles published with a CC BY NC SA or
CC BY NC ND license reguires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
•
•
•
•

Associating advertising with the full text of the Article
Charging fees for document delivery or access
Article aggregation
Systematic distribution via e-mail lists or share buttons

Posting or linking by commercial companies for use by customers of those companies.
20 Other Conditions:

V1.10
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or +1-978-646-2777.
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Springer Nature Custom« Service Centre GmbH
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1.2. The Licensor warrants that it has, to the best of its knowledge, the rights to license reuse of the Licensed Material.
However, you should ensure that the material you are requesting is original to the Licensor and does not carry the copyright
of another entity (as credited in the published version).
1.3. If the credit line on any part of the material you have requested indicates that it was reprinted or adapted with permission
from another source, then you should also seek permission from that source to reuse the material.

2. Scope of Licence
2. 1. You may only use the Licensed Content in the manner and to the extent permitted by these Ts&Cs and any applicable
laws.
2. 2. A separate licence may be required for any additional use of the Licensed Material, e.g. where a licence has been
purchased for print only use, separate permission must be obtained for electronic re-use. Similarly, a licence is only valid in
the language selected and does not apply for editions in other languages unless additional translation rights have been
granted separately in the licence. Any content owned by third parties are expressly excluded from the licence.

2. 3. Similarly, rights for additional components such as custom editions and derivatives require additional permission and
may be subject to an additional fee. Please apply to
JournalDermissions@sprinqernature.com/bookpermissions@SDrinqernature.com for these rights.
2. 4. Where permission has been granted free of charge for material in print, permission may also be granted for any
electronic version of that work, provided that the material is incidental to your work as a whole and that the electronic version
is essentially equivalent to, or substitutes for, the print version.

2. 5. An alternative scope of licence may apply to signatories of the $TM Permissions Guidelines, as amended from time to
time.

3. Duration of Licence
3.1. A licence for is valid from the date of purchase ('Licence Date') at the end of the relevant period in the below table:

Scope of Licence

Duration of Licence

Post on a website

12 months

Presentations
Books and journals

12 months
Lifetime of the edition in the language purchased

4. Acknowledgement

4.1. The Licensor's permission must be acknowledged next to the Licenced Material in print. In electronic form, this
acknowledgement must be visible at the same time as the figures/tables/illustrations or abstract, and must be hyperlinked to the
journal/book's homepage. Our required acknowledgement format is in the Appendix below.

5. Restrictions on use
5. 1. Use of the Licensed Material may be permitted for incidental promotional use and minor editing privileges e.g. minor
adaptations of single figures, changes of format, colour and/or style where the adaptation is credited as set out in Appendix 1
below. Any other changes including but not limited to, cropping, adapting, omitting material that affect the meaning, intention or
moral rights of the author are strictly prohibited.
5. 2. You must not use any Licensed Material as part of any design or trademark.
5. 3. Licensed Material may be used in Open Access Publications (OAP) before publication by Springer Nature, but any Licensed
Material must be removed from OAP sites prior to final publication.
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6. Ownership of Rights

6.1. Licensed Material remains the property of either Licensor or the relevant third party and any rights not explicitly granted
herein are expressly reserved.

7. Warranty

IN NO EVENT SHALL LICENSOR BE LIABLE TO YOU OR ANY OTHER PARTY OR ANY OTHER PERSON OR FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL OR INDIRECT DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, VIEWING OR USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE, INFRINGEMENT OR OTHERWISE
(INCLUDING, WITHOUT LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS
OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND
WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION SHALL
APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.

8. Limitations
8. 1. BOOKS ONLY:\NY\ere 'reuse in a dissertation/thesis' has been selected the following terms apply: Print rights of the final
author’s accepted manuscript (for clarity, NOT the published version) for up to 100 copies, electronic rights for use only on a
personal website or institutional repository as defined by the Sherpa guideline (www.sherpa.ac.uk/rorneo/)
8. 2. For content reuse requests that qualify for permission under the STM Permissions Guidelines, which may be updated from
time to time, the STM Permissions Guidelines supersede the terms and conditions contained in this licence.

9. Termination and Cancellation
9. 1. Licences will expire after the period shown in Clause 3 (above).
9. 2. Licensee reserves the right to terminate the Licence in the event that payment is not received in full or if there has been a
breach of this agreement by you.

Appendix 1 — Acknowledgements:
For Journal Content:
Reprinted by permission from [the Licensor]: [Journal Publisher (e.g. Nature/Springer/Palgrave)] [JOURNAL NAME]
[REFERENCE CITATION (Article name, Author(s) Name), [COPYRIGHT] (year of publication)

For Advance Online Publication papers:
Reprinted by permission from [the Licensor]: [Journal Publisher (e.g. Nature/Springer/Palgrave)] [JOURNAL NAME]
[REFERENCE CITATION (Article name, Author(s) Name), [COPYRIGHT] (year of publication), advance online publication,
day month year (doi: 10.1038/sj.[JOURNAL ACRONYM].)
For Adaptations/Translations:
Adapted/Translated by permission from [the Licensor]: [Journal Publisher (e.g. Nature/Springer/Palgrave)] [JOURNAL
NAME] [REFERENCE CITATION (Article name, Author(s) Name), [COPYRIGHT] (year of publication)

Note: For any republication from the British Journal of Cancer, the following credit line style applies:
Reprinted/adapted/translated by permission from [the Licensor]: on behalf of Cancer Research UK: [Journal Publisher
(e.g. Nature/Springer/Palgrave)] [JOURNAL NAME] [REFERENCE CITATION (Article name, Author(s) Name),
[COPYRIGHT] (year of publication)

For Advance Online Publication papers:
Reprinted by permission from The [the Licensor]: on behalf of Cancer Research UK: [Journal Pu blisher (e.g.

https://s100.copyright.com/MyAccount/Web/jsp/viewprintablelicensefrommyorders.jsp?ref=2e3c5cfc-d1d1-44d5-9d32-81a9bbcc765b&email=

100

3/4

RightsLink - Your Account

1/12/2021
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1.2. The Licensor warrants that it has, to the best of its knowledge, the rights to license reuse of the Licensed Material.
However, you should ensure that the material you are requesting is original to the Licensor and does not carry the copyright
of another entity (as credited in the published version).
1.3. If the credit line on any part of the material you have requested indicates that it was reprinted or adapted with permission
from another source, then you should also seek permission from that source to reuse the material.

2. Scope of Licence
2. 1. You may only use the Licensed Content in the manner and to the extent permitted by these Ts&Cs and any applicable
laws.
2. 2. A separate licence may be required for any additional use of the Licensed Material, e.g. where a licence has been
purchased for print only use, separate permission must be obtained for electronic re-use. Similarly, a licence is only valid in
the language selected and does not apply for editions in other languages unless additional translation rights have been
granted separately in the licence. Any content owned by third parties are expressly excluded from the licence.

2. 3. Similarly, rights for additional components such as custom editions and derivatives require additional permission and
may be subject to an additional fee. Please apply to
JournalDermissions@sprinqernature.com/bookpermissions@SDrinqernature.com for these rights.
2. 4. Where permission has been granted free of charge for material in print, permission may also be granted for any
electronic version of that work, provided that the material is incidental to your work as a whole and that the electronic version
is essentially equivalent to, or substitutes for, the print version.

2. 5. An alternative scope of licence may apply to signatories of the $TM Permissions Guidelines, as amended from time to
time.

3. Duration of Licence
3.1. A licence for is valid from the date of purchase ('Licence Date') at the end of the relevant period in the below table:

Scope of Licence

Duration of Licence

Post on a website

12 months

Presentations
Books and journals

12 months
Lifetime of the edition in the language purchased

4. Acknowledgement

4.1. The Licensor's permission must be acknowledged next to the Licenced Material in print. In electronic form, this
acknowledgement must be visible at the same time as the figures/tables/illustrations or abstract, and must be hyperlinked to the
journal/book's homepage. Our required acknowledgement format is in the Appendix below.

5. Restrictions on use
5. 1. Use of the Licensed Material may be permitted for incidental promotional use and minor editing privileges e.g. minor
adaptations of single figures, changes of format, colour and/or style where the adaptation is credited as set out in Appendix 1
below. Any other changes including but not limited to, cropping, adapting, omitting material that affect the meaning, intention or
moral rights of the author are strictly prohibited.
5. 2. You must not use any Licensed Material as part of any design or trademark.
5. 3. Licensed Material may be used in Open Access Publications (OAP) before publication by Springer Nature, but any Licensed
Material must be removed from OAP sites prior to final publication.
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of another entity (as credited in the published version).

1.3. If the credit line on any part of the material you have requested indicates that it was reprinted or adapted with permission
from another source, then you should also seek permission from that source to reuse the material.

2. Scope of Licence
2. 1. You may only use the Licensed Content in the manner and to the extent permitted by these Ts&Cs and any applicable
laws.
2. 2. A separate licence may be required for any additional use of the Licensed Material, e.g. where a licence has been
purchased for print only use, separate permission must be obtained for electronic re-use. Similarly, a licence is only valid in
the language selected and does not apply for editions in other languages unless additional translation rights have been
granted separately in the licence. Any content owned by third parties are expressly excluded from the licence.

2. 3. Similarly, rights for additional components such as custom editions and derivatives require additional permission and
may be subject to an additional fee. Please apply to
Journalpermissions@sprinqemature.com/bookpermissions@sprinqernature.com for these rights.
2. 4. Where permission has been granted free of charge for material in print, permission may also be granted for any
electronic version of that work, provided that the material is incidental to your work as a whole and that the electronic version
is essentially equivalent to, or substitutes for, the print version
2. 5. An alternative scope of licence may apply to signatories of the STM Permissions Guidelines, as amended from time to
time.

3. Duration of Licence
3.1. A licence for is valid from the date of purchase ('Licence Date') at the end of the relevant period in the below table:

Scope of Licence
Post on a website

Duration of Licence
12 months

Presentations

12 months

Books and journals

Lifetime of the edition in the language purchased

4. Acknowledgement

4.1. The Licensor's permission must be acknowledged next to the Licenced Material in print. In electronic form, this
acknowledgement must be visible at the same time as the figures/tables/illustrations or abstract, and must be hyperlinked to the
journal/book's homepage. Our required acknowledgement format is in the Appendix below.
5. Restrictions on use
5. 1. Use of the Licensed Material may be permitted for incidental promotional use and minor editing privileges e.g. minor
adaptations of single figures, changes of format, colour and/or style where the adaptation is credited as set out in Appendix 1
below. Any other changes including but not limited to, cropping, adapting, omitting material that affect the meaning, intention or
moral rights of the author are strictly prohibited.
5. 2. You must not use any Licensed Material as part of any design or trademark.
5. 3. Licensed Material may be used in Open Access Publications (OAP) before publication by Springer Nature, but any Licensed
Material must be removed from OAP sites prior to final publication.
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